bibliography -...
TRANSCRIPT
Bibligraphy
174
BIBLIOGRAPHY
Abbas ZG, Archibald LK. Epidemiology of the diabetic foot in Africa. Med Sci Monit
11(8):RA262-RA270, 2005.
Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study:
Incidence of, and risk factors for, new diabetic foot ulceration in a community-
based patient cohort. Diabet Med 2002; 19(5):377-384.
Abbott CA, Vileikyte L, Williamson S, Carrington AL, et al. Multicenter study of the
incidence of and predictive risk factors for diabetic neuropathic foot ulceration.
Diabetics Care. 1998; 21: 1071-1075.
Abbott CA, Vileikyte L, Williamson S, et al. Multicentre study of the incidence of and
predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 2004;
94(5):379–83.
Abdulrazak A, Bitar ZI, Al-Shamali AA, and Mobasher LA. Bacteriological study of
diabetic foot infections. J. Diabetes Complications 2005; 19:138-141.
Adera HM, James K, Castronuovo JJ, Byrne M, et al. Prediction of amputation wound
healing with skin perfusion pressure. J. Vasc. Surg 1995; 21: 823-829.
Adler AI, Boyko EJ, Ahroni J, Smith DG. Lower extremity amputation in diabetes:
the independent effects of peripheral vascular disease, sensory neuropathy, and
foot ulcers. Diabetes Care 1999; 22:1029-1035.
Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59:
hyperglycemia and other potentially modifiable risk factors for peripheral vascular
disease in type 2 diabetes. Diabetes Care. 2002; 25:894-899.
Ahuja MMS. Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS,
editor. Epidemiology of diabetes in developing countries. New Delhi: Interprint
1979; 29-38.
Aiello LP, Bursell SE, Clemont A, et al: Vascular endothelial growth factor induced
retinal permeability is mediated by protein kinase C in vivo and suppressed by an
orally effective B- isoform selective inhibitor. Diabetes 1997 ; 46:1473-1480.
Ajello L, Hay RJ. Medical mycology. In: Topley & Wilson’s microbiology and
microbial infctions, 9th ed. London: Arnold, 1998.
Bibligraphy
175
Akbari CM, LoGerfo FW. The impact of micro-and macrovascular disease on
diabetic neuropathy foot problems. In: Clinical Management of neuropathy, pp.319-
331, edited by A Veves, Humana Press, Totowa, NJ, 1998.
Akira N, Mic H and Taiji N. Antibiotic stress induces large amount of
outermembrane protein in Pseudomonas aeruginosa, FEMS Micro Lett 1998; 165 :
261–265.
Ako-Nai AK, Ikem IC, Akinloye OO, Aboderin AO, et al. Characterization of
bacterial isolates from diabetic foot infections in Ile-Ife, Southwestern Nigeria. The
Foot. 2006; 16, 3, 158-164.
Alberti KG , Zimmet PZ. Definition diagnosis and classification of diabetes
mellitus and its complications. Part I: Diagnosis and classification of
diabetes mellitus, provisional report of a WHO consultation. Diabetes Med
1998; 15 : 539-53.
Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, et al. Effect of type 2 diabetes
and its duration on the risk of peripheral arterial disease among men. Am J Med
2004; 116:236–40.
Alekseev AA, Krutikov MG, Kolokol'chikova EG, Chervonskaia NV, et al. The
causative agent of wound infection and sepsis in burn patients. Zh. Mikrobiol.
Epidemiol. Immunobiol 1996; 5:84-86.
Alexander CM, Landsman PB, Teutsh SM, Haffner SM. Third National Health and
Neutrition Examination Survey (NHANES-III). National Choleterol Education
Program (NCEP): NCEP-defined metabolic syndrome, diabetes and prevalence of
coronary heart disease among NHANES III participants age 50 years and older.
Diabetes 2003; 52(5):1210-1214.
Alexander RW, Schlant, Fuster V, editors. The heart. 9th edn. New York: McGraw-
Hill; 1998.
Al-Haj-Hussein BT, Al-Shehri MA, Azhar EA, et al. Evaluation of 2 real-time PCR
assays for the investigation of mecA gene in clinical isolates of MRSA in western
Saudi Arabia. Saudi Med J 2005; 26:759-762.
Alobwede I, M’Zali FM, Livermore DM, et al. CTX-M extended-spectrum beta-
lactamase arrives in the UK. J. Antimicrob Chemother 2003. 51:470–471.
Ambler RP, Coulson AF, Frere JM, et al.. A standard numbering scheme for the class
A beta-lactamases. Biochem. J 1991; 276: 269–270.
American Diabetes Association. Consensus development conference on diabetic
foot wound care. Diabetes Care 1999; 22, 1354–60.
Bibligraphy
176
American Diabetes Association. Implications of the Diabetes Control and
Complications Trial. Diabetes Care 2000; 23:S24-S26.
American Diabetes Association. Implications of the United Kingdom Prospective
Diabetes study. Diabetes Care. 2000; 23(1):S27-S31.
American Diabetes Association. Peripheral arterial disease in people with
diabetes. Diabetes Care 2003; 26: 3333– 41.
American Diabetes Association. Report of the expert Committee on the diagnosis
and classification of diabetes mellitus. Diabetes Care 2000; 23 (1): S4-S19.
American Diabetes Association. Standards of Medical Care in
diabetes2008. Diabetes Care 2008 31:S12-S54.
American Diabetic Association. Clinical Practice Recommendations 1995.
Diabetic Care 18:8-15, 1995.
American Diabetes Consensus Development Conference on Diabetic Wound
Care. Diabetes Care 1999; 22:1354.
Amos AF, McCarty DJ, Zimmet P, The rising global burden of diabetes and its
complications: estimates and projections to the year 2010, Diabet Med 1997; 14 (5)
S1–S85.
Andrew S. Powlson and Anthony PC. The treatment of diabetic foot infections. J
Antimicrob Chemother 2010; 65 (3): 3–9.
Apelqvist J, Castenfors J, Larsson J. Wound classification is more important than
site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 1989; 6:526-
530.
Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors
and peripheral neuropathy on the development and outcome of diabetic foot ulcers.
J Diab Compl 1990; 4:21.
Apelqvist J, Larsson J, Ragnarsson-Tennvll G, et al. Long term costs in diabetic
patients with foot ulcers. Foot and Ankle 1995; 16: 388-394.
Apelqvist J, Larsson J. What is the most effective way to reduce incidence of
amputation in the diabetic foot?. Diabetes Metab. Res. Rev 2000;16:S75–S83.
Apelqvist J, Castenfors J, Larsson J, et al. Prognostic value of systolic ankle and toe
pressure levels in outcome of diabetic foot ulcers. Diabetes Care 1989; 12: 373-378.
Apelqvist J, Larsson J, Agardh CD. Long term prognosis for patients with foot
ulcers. J. Intern. Med 1993; 233:485-491.
Bibligraphy
177
Apfel SC. Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol
1999; 419 (I):27-34.
Armstrong DG, Joseph WS, Lavery L, et al. Treating MRSA infections. Experts share
their insights on diagnosis and treatment. Wounds 2004; S1–S23.
Armstrong DG, Larvey LA, Harkless LB. Validation of wound classification system:
the contribution of depth, infection, and ischemia to risk of amputation. Diabetes
Care 1998; 21:855-859.
Armstrong DG, Larvey LA, Sariaya M, et al. Leukocytosis is a poor indicator of acute
osteomyelitis of the foot in diabetes mellitus. J. Foot Ankle Surg 1996; 35:280-283.
Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and
classification. Am Fam Physician 1998; 57: 1325-32.
Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections.
Diabetes Technol Ther 2004, 6(2): 167-177.
Armstrong DG, Liswood PJ, Todd WF. Prevalence of mixed infections in the
diabetic pedal wound: a retrospective review of 112 infections. 1995 William J.
Stickel bronze award. J Am Podiatr Med Assoc 1995; 85:533–7.
Armstrong DG, Perales TA, Muriff RT, et al. Value of white blood cell count with
differential in the acute diabetic foot infection. J. Am. Podiatr. Med. Assoc1996;
86:224-227.
Armstrong DG, Peters EJG, Athanasiou KA, et al. Is there a critical level of planter
foot pressure to identify patients at risk for neuropathic foot ulcerations? J Foot
Ankle Surg 1998; 37(4):303-307.
Armstrong DG, Stephan KT, Joseph, et al. What is the shelf –life of physician-
mixed antibiotic-impregnated calcium sulphate pellets? J Foot Ankle Surg 2003,
42(5): 302-304.
Austin TW, Austin MA, McAlear DE, et al. MRSA prevalence in a teaching hospital in
Western Saudi Arabia. Saudi Med J 2003; 24:1313-1316.
Axler DA. Microbiology of diabetic foot infections. J Foot Surg 1987; 26:S3–6.
Babypadmini S, Appalaraju B. Extended-spectrum β -lactamases in urinary isolates
of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility
pattern in a tertiary care hospital. Indian J Med Microbiol 2004; 22:172-4.
Bader M, Jafri AK, Krueger T, et al. Fusarium Osteomyelitis of the Foot in a Patient
with Diabetes Mellitus. Scand. J. Infect. Dis 2003; 35 (11-12), 895-896.
Bibligraphy
178
Bailey & Scott’s Diagnostic Microbiology. Twelfth Edition International. Published
by Mosby Elseiver. 2007.
Baird D. Staphylococcus: cluster-forming gram-positive cocci. In Mackie &
McCartney Practical Medical Microbiology. 14th ed. Collee JG, Fraser AG, Marmion
BP, Simmons A, Eds. New York, Churchill Livingstone, 1996, p. 245–261.
Baker SR, Stacey MC, Jopp-McKay AG. et al. Epidemiology of chronic venous ulcers.
British Journal of Surgery 1991; 78, 864–7.
Baraniak A, Fiett J, Hryniewicz W, et al . 2002. Ceftazidime-hydrolysing CTX-M-15
extended-spectrum beta-lactam- ase (ESBL) in Poland. J. Antimicrob. Chemother.
50:393–396.
Baron EJ: The detection, significance, and rationale for control of methicillin
resistant StaphylococcuS. aureus. Clin Microbiol Newslett. 1992; 14:129-136.
Barrett JP, Mooney V. Neuropathy and diabetic pressure lesions. Orthop Clin North
Am 4:43-47, 1973.
Beach KW, Bedford GR, Bergelin RO, et al. Progression of lower-extremity arterial
occlusive disease in type 2 diabetes mellitus. Diabetes Care 1998; 11:464–472.
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. Epidemiology,
pathophysiology and management. JAMA. 2002; 287: 2570–81.
Beezhold DH, Personius C. fibronectin fragments stimulate tumour necrosis factor
secretion by human monocytes. J Leukoc Biol 1992, 51: 59-64.
Beggs J, Johnson PC, Olafsen A, Watkins CJ. Innervation of the vasa nervorum:
Changes in human diabetics. J Neuropathol Exp Neurol 51:612-629, 1992.
Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral
arterial disease in relation to glycaemic level in an elderly Caucasian population:
the Hoorn study. Diabetologia. 1995; 38:86 –96.
Bendermacher BL, Teijink JA, Willigendael EM, et al. A clinical prediction model
for the presence of peripheral arterial disease—the benefit of screening individuals
before initiation of measurement of the ankle-brachial index: an observational
study. VascMed 2007;12(1):5–11.
Bendy RH, Nuccio PA, Wolfe E, et al. Relationship of quantitative wound bacterial
counts to healing of decubiti. Effect of topical gentamicin. Antimicrobial Agents and
Chemotherapy 1964; 4, 147–55.
Benton GS, Kerstein MD. Cost effectiveness of early digit amputation in the
inpatient with diabetes. Surg Gynecol Obstet. 1985; 161: 523–4.
Bibligraphy
179
Bernstein EF, Fronek A. Current status of non-invasive tests in the diagnosis of
peripheral arterial disease. Surg Clin North Am 1982;62:473–87.
Bessman AN, Geiger PJ, Canawati H. Prevalence of Corynebacteria in diabetic foot
infections. Diabetes Care 1992; 15:1531–3.
Bessman AN, Sapico FL, Tabatabai M, et al. Persistence of polymicrobial abscesses
in the poorly controlled diabetic host. Diabetes 1986; 35:448–53.
Bessman AN, Wager FW, Jr. Nonclostridial gas gangrene. J Am Med Assoc. 1965;
233:958-963.
Bhavnani SM, Ambrose PG, Craig WA, et al. SENTRY Antimicrobial Surveillance
Program: Outcomes evaluation of patients with ESBL- and non-ESBL-producing
Escherichia coli and Klebsiella species as defined by CLSI reference methods: report
from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis.
2006; 54: 231-236.
Biedenbach DJ, Moet GJ, Jones RN: Occurrence and antimicrobial resistance
pattern comparisons among bloodstream infection isolates from the SENTRY
Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis. 2004;
50:59-69.
Bild DE, Selby JV, Sinnock P, et al. Lower extremity amputation in people with
diabetes: epidemiology and prevention. Diabetes Care. 1989; 12: 24 –31.
Birke IA, Cornwall MW, Jackson M. Relationship between hallux limitus and
ulceration of the great toe. Journal of Orthopaedic and Sports Physical Therapy.
1988; 10: 172-176.
Birke IA, Sims DS. The insensitive foot. In: Hunt GC (ed). Physical therapy for the
foot and ankle. Churchill Livingstone, New York 1988:133-168.
BokyoEJ, Ahroni JH, CohenV, et al. Prediction of diabetic foot ulcer occurrence
using commonoly available clinical information: The Seatle Diabetic Foot Study.
Diabetes Care29(6):1202-1207, 2006.
Bolton WK, Cattran DC, Williams ME et al. Randomized trial of an inhibitor of
formation of advanced glycation end products in diabetic nephropathy. Am J
Nephrol. 2004; 24: 32-40.
Bone GE, Pomajl MJ. Toe blood pressure by photoplethysmography. An index of
healing in forefoot amputation. Surgery. 1981; 89:569.
Bonfiglio G, Carciotto V, Russo G, et al. Antibiotic resistance in Pseudomonas
aeruginosa: an Italian survey, J Antimicrob Chemother. 1998; 4: 307–310.
Bibligraphy
180
Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M
enzymes. Antimicrob. Agents Chemother 2004; 48:1–14.
Borch-Johnsen K. The newclassification of diabetes mellitus and IGT: A critical
approach. Exp Clin Endocrinol Diabetes 2001; 109 (suppl 2):S86-S93.
Borrero E, Rossini M Jr. Bacteriology of 100 consecutive diabetic foot infections
and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin. Angiology.
1992; 43:357–61.
Bou GM. Cartelle M. Tomas D. et al.. Identification and broad dissemination of the
CTX-M-14 beta-lactamase in different Escherichia coli strains in the north- west
area of Spain. J. Clin. Microbiol 2002; 40:4030–4036.
Boulton AJ, Meneses P, Ennis WJ. Diabetic foot ulcers. A framework for prevention
and care. Wound Rep. Reg. 1999; 7:7-17.
Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnostic and outpatient
management of diabetic peripheral neuropathy. Diabet Med 15:508-514, 1998.
Boulton AJM, Kirsner RS, Vileikyte L: Neuropathic diabetic foot ulcers. N Engl J
Med. 2004; 351:48-55.
Boulton AJM, Vileikyte L, Ragnarson – Tennvall G et al. The Global burden of
diabetic foot disease. Lancet 2005;366:1719-24.
Boulton AJM. The pathogenesis of diabetic foot problems: an over view. Diabetic
Med. 1996; 13:S12-S16.
Boulton AJM. The pathways to ulceration. The foot in Diabetes, 3rd ed.,pp. 19-31
edited by AJM Boulton, H Connor, and PR Cavangh, John Wiley and Sons, Chichseter,
UK, 2000.
Boulton AJM: Why bother educating the multidisciplinary team and the patient: the
example of prevention of lower extremity amputation in diabetes. Patient Educ
Counsel. 1995; 26:183–188.
Bowering CK: Diabetic foot ulcers: pathophysiology, assessment, and therapy. Can
Fam Phys 2001; 47:1007–1016.
Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers.
International Journal of Dermatology. 1999; 38, 573–578.
Bowler PG, Davies BJ. The microbiology of acute and chronic wounds. Wounds.
1999; 11, 72–8.
Bowler PG, Duerden BI, and Armstrong DG. Wound microbiology and associated
approaches to wound management. Clin. Microbiol. Rev. 2001; 14:244-269.
Bibligraphy
181
Bowler PG. The 105 bacterial growth guideline: reassessing its clinical relevance in
wound healing. Ostomy Wound Manage. 2003; 49(1):44–53.
Bowler PG. Wound pathophysiology, infection and therapeutic options. Ann Med
2002, 34(6): 419-427.
Boyko EJ, Ahroni JH, Stensel V, et al. A prospective study of risk factors for diabetic
foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999; 22:1036-42.
Boyko EJ, Lipsky BA. Infection and diabetes mellitus. In Harris MI (ed): Diabetes in
America, 2nd edition. NIH publication No 95-1468. Bethesda, MD: National
Institute of Health. 1995, pp 485-499.
Bradford PA. Extended-spectrum beta-lactamases in the 21st cen- tury:
characterization, epidemiology, and detection of this important resis- tance threat.
Clin. Microbiol. Rev 2001; 14:933–951.
Brand PW. Repetitive stress in the development of diabetic foot ulcers. In: The
Diabetic foot, 4th ed, edited by M.E. Levin, and JK Davidson, Mosby, St Louis, MO,
1988; ., pp83-90.
Brand PW: the diabetic foot. In: Ellenburg M, Rifkin H (eds). Diabetes mellitus:
theory and practice, ed 3. Medical Examination Publishing Co. Inc., New Hyde Park,
N.Y. 1983; 829-849.
Brenwald N P, Jevons G, Andrews JM, et al. An outbreak of a CTX-M-type beta-
lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime
to detect ex- tended-spectrum beta-lactamases. J. Antimicrob. Chemother 2003;
51:195–196.
Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly
characterized receptor for advanced glycation end products in tissues. American
Journal of Pathology 1993; 143, 1699–1712.
Bridges RM, Deitch EA. Diabetic foot infections: Pathophysiology and treatment.
Surg Clin North Am 1994, 74: 537-555.
British National Formulary. British National Formulary 2004; Vol. 47. British
Medical Association and The Royal Pharmaceutical Society of Great Britain, London,
UK.
Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers.
International Journal of Dermatology. 1998; 37, 426–8.
Bibligraphy
182
Brownlee M, Aiello LP, Friedman E, et al. Complications of Diabetes Mellitus. In:
Williams Textboot of Endocrinology. 10th ed. 2003 (eds) Larsen R, Krokenberg HM,
Melmed S, Polonsky KS. Suunders pp 1560-1563.
Brownlee M. Biochemistry and Molecular cell biology of diabetic complications.
Nature. 2001; 414: 813-820.
Brumfitt W, Hamilton-Miller J. Methicillin-resistant StaphylococcuS. aureus. New
Engl J Med. 1989; 320:1188-1196.
Brun-Buisson C, Legrand P, Philippon A, et al. Transferable enzymatic resistance
to third-generation cephalosporins during nosocomial outbreak of multiresistant
Klebsiella pneumoniae. Lancet 1987; ii:302–306.
Bukharie HA, Abdelhadi MS. The epidemiology of Methicillin-resistant
StaphylococcuS. aureus at a Saudi University Hospital. Microb Drug Resist. 2001;
7:413-416.
Busch U and Nitschko H. Methods for the differentiation of microorganisms, J
Chromatogr B. 1999; 722: 263–278.
Bush KC. Macalintal, B. A. Rasmussen, et al.. Kinetic interactions of tazobactam
with beta-lactamases from all major structural classes. Antimicrob. Agents
Chemother 1993; 37:851–858.
Bush KG. Jacoby A, Medeiros AA. A functional classification scheme for beta-
lactamases and its correlation with molecular structure. Antimicrob. Agents
Chemother 1995; 39:1211–1233.
Caballero E, Frykberg RG. Diabetic foot infections. J. Foot. Ankle surg.1998; 37:248-
255.
Calhoun JH, Cantrell J, Cobos J, et al. Treatment of diabetic foot infections: Wagner
classification, therapy, and outcome. Foot Ankle. 1988; 9:101–6.
Calhoun JH, Overgaard KA, Stevens CM, et al. Diabetic foot ulcers and infections:
current concepts. Adv Skin Wound Care 2002;15:31-45.
Callam MJ, Ruckley CV, Harper DR. et al. Chronic ulceration of the leg: extent of the
problem and provision of care. British Medical Journal 1985; 290, 1855–6.
Cameron NE, Cotter MA. Basso M, et al. Comparison of the effects of inhibitors of
aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve
conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Diabetilogica 1997; 40:271-281.
Bibligraphy
183
Cameron NE, Cotter MA. Comparison of the effects of ascorbyl µ-linolenic acid and
µ-linolenic acid in the correction of neurovascular deficits in diabetic rats.
Diabetilogica 1996; 39:1047-1054.
Cameron NE, Cotter MA. Hohman TC. Interaction between essential fatty acid,
prostanoid polyol pathway and nitric oxide mechanisms in the neurovascular
deficit of diabetic rats. Diabetilogica 1996; 39:172-182.
Cameron NE, CottorMA. Metabolic and vascular factors in the pathogenesis of
diabetic neuropathy. Diabetes 1997; 46(suppl 2):S31-S37.
Canal N, Nemni R. Autoimmunity and diabetic neuropathy. Clin Neurosci 1997;
4:371-373.
Cao V, Lambert T, Nhu DQ, et al. Distribution of extended-spectrum beta-
lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob.
Agents Che- mother 2002; 46:3739–3743.
Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot
disease in patients with diabetes. N Engl J Med. 1994; 331:854–860.
Carbayo JA, Divison JA, Escribano J, et al. Using ankle-brachial index to detect
peripheral arterial disease: prevalence and associated risk factors in a random
population sample. Nutr Metab Cardiovasc Dis 2007;17(1): 41–9.
Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438: 932-
936.
Carrington AL, Shaw JE, Van Schie CH, et al. Can motor nerve conduction velocity
predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes
Care 25(11):2010-2015, 2002.
Castronuovo JJ, Adera HM, Smiell JM, et al. Skin perfusion pressure measurement is
valuable in the diagnosis of critical limb ischemia. J. Vasc. Surg. 1997; 26 :629-637.
Catherine ASC, Myrna TM, Marissa MA, et al. Microbiologic and Clinical Profile of
Anaerobic Diabetic Foot Infections. Phil J Microbiol Infect Dis. 2002; 31(4):151-
160]
Cederna JE, Terpenning MS, Ensberg M, et al Staphylococcus. aureus nasal
colonization in a nursing home: eradication with mupirocin. Infect Control Hosp
Epidemiol. 1990 ; 11:13-16.
Center for Disease Control and Prevention. Prevalence of diabetes. Available at:
http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.
Bibligraphy
184
Centers for Disease Control and Prevention. Public Health Dispatch:
vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. Morbidity and
Mortality Weekly Report 2002; 51, 902.
Centers for Disease Control and Prevention. Staphylococcus aureus resistant to
vancomycin—United States, 2002. Morbidity and Mortality Weekly Report 2002;
51, 565–7.
Centres for Disease Control and Prevention: History of foot ulcer among persons
with diabetes: United States, 2000-2002, MMWR Morb Mortal Wkly Rep 2003;
52(45):1098-1103,.
Chaibi EB, Sirot D, Paul G, et al. Inhibitor-resistant TEM beta-lactamases:
phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother
1999; 43:447–458.
Chanawong A, M’Zali FM, Heritage J, et al.. Three cefotaximases, CTX-M-9, CTX-M-
13, and CTX-M-14, among Enterobacteriaceae in the People’s Republic of China.
Antimicrob. Agents Chemother 2002; 46:630–637.
Chandler FW, Kaplan W, Ajello L. Color atlas and textbook of histopathology of
mycotic disease. Chicago: year book Medical Publisher, 1980.
Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant
StaphylococcuS. aureus containing the vanA resistance gene. N Engl J Med. 2003;
348:1342-1347.
Chantelau E, Lee KM, Jungblut R. Association of below knee atherosclerosis to
medial arterial calcification in diabetes mellitus. Diabetes Res. Clin. Prac. 1995 ; 29:
169-172.
Chantelau E, Tanudjaja T, Altenhofer F, et al. Antibiotic treatment for
uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet
Med. 1996; 13:156–9.
Charonis AS, Tsilbary EC. Structural and functional changes of laminin and type 4
collagen after non enzymatic glycation. Diabetes. 1992 ; 41 (Suppl 2 ) : 49-51.
Chaturvedi N, Abbott CA, Whalley A, et al. Risk of diabetes-related amputations in
South Asians vs Europeans in the UK. Diabet Med 2002; 19(2):99-104.
Chaturvedi N, Stevens LK, Fuller JH, et al. Risk factors, ethnic difference and
mortality associated with lower extremity gangrene and amputation in diabetes.
Diabetiologica 2001; 44(suppl 2):S65-S71.
Bibligraphy
185
Chellan G, Shivaprakash S, Karimassery Ramaiyar S, et al. Spectrum and prevalence
of fungi infecting deep tissues of lower-limb wounds in patients with type 2
diabetes. J Clin Microbiol. 2010; 48(6):2097-102.
Cheng HM, González RG. The effect of high glucose and oxidative stress on lens
metabolism, aldose reductase, and senile cataractgenesis. Metabolism. 1986 ; 35 (4
Suppl): 10-14.
Cheng SW, Ting AC, Lau H, et al. Epidemiology of atherosclerotic peripheral arterial
occlusive disease in Hong Kong. World J Surg 1998; 23:202–206.
Cheng Y, Li Y, Chen M. A plasmid-mediated SHV type extended-spectrum beta-
lactamase in Beijing isolate of Enterobacter gergoviae. Wei Sheng Wu Xue Bao 1994
; 34:106–112.
Cheresh DA. Human endothelial cell synthesize and express an Arg-Gly-Asp-
directed adhesion receptor involved in attachment to fibrinogen and von
Willebrand factor. Proc Natl Acad Sci USA 1987, 84: 6471-6475.
Cherry GC, Hughes MA, Ferguson MWJ, et al. Wound healing: In Morris PJ, Wood
WC (eds): Oxford textbook of surgery. Oxford UK: Oxford University Press, 2000.
131-159.
Chincholikar DA, Pal R. Study of fungal and bacterial infections of diabetic foot.
Indian Journal of Pathology and Microbiology 2002; 45: 15-22.
Chitnis SV, Chitnis V, Sharma N et al. Current status of drug resistance among gram
negative bacilli isolated from admitted cases in tertiary care centre, J Assoc
Physicians India 2003; 51:28–32.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood
Pressure: The JNC 7 Report. JAMA 2003; 289: 2560- 2572.
Clark RAF. Wound repair: Overview amd general considerations. In Clark RAF (ed):
the Molecular and Cellular Biology of wound Healing. New York: Plenum Press,
1996, pp 3-50.
Clinical and Laboratory Standards Institute. Antifungal Susceptibility testing of
yeast. M24A. Wayne, PA, Clinical and Laboratory Standards Institute, 2007.
Clinical and Laboratory Standards Institute: Performance Standards for
Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement.
M100-S17, vol. 27, no. 1. Wayne, PA, Clinical and Laboratory Standards Institute,
2007.
Bibligraphy
186
Clinical and Laboratory Standards Institute: Performance Standards for
Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement.
M100-S17, vol. 27, no. 1. Wayne, PA, Clinical and Laboratory Standards Institute,
2007.
Cole JA, Walker RE, Yordy MR. Hyperglycemia induced changes in Na+ /myo-
inositol transport, Na(+)-K(+)-ATPase, and protein kinase C activity in proximal
tubule cells. Diabetes 1995; 44:446-452.
Coleman WC. Footwear considerations. In: The high-risk foot in diabetes mellitus.
1991; Frykberg RG (ed). Churchill Livingstone, New York 487-496.
Colsky AS, Kirsner RS, Kerdel FA. Analysis of antibiotic susceptibilities of skin
wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance
has come to the surface. Archives Dermatology 1998; 134, 1006–1009.
Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother. 1990
; 25:497-503.
Cooper CR Jr, McGinnis MR. Pathology of Penicillium marneffei. An emerging
acquired immunodeficiency syndrome-related pathogen. Arch. Pathol. Lab. Med
1997; 121, 798-804.
Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used
topical antimicrobial agents on human fibroblasts and keratinocytes. Journal of
Trauma 1991; 31, 775–84.
Cosgrove SE. & Carmeli, Y. The impact of antimicrobial resistance on health and
economic outcomes. Clinical Infectious Diseases 2003; 36, 1433–7.
Craven PA, Davidson CM, DeRubertis FR. Increase in diacylglcerol mass in isolated
glomeruli by glucose from denovo synthesis of glycerolipids. Diabetes. 1990;
39:667-674.
Ctercteko GC, Dhanendran M, Hutton WC, et al. Vertical forces acting on the feet of
diabetic patients with neuropathic ulceration. British J Surgery. 1981 ;68:608-6 14.
Cui L, Ma K, Sato K, et al. Cell Wall Thickening Is a Common Feature of Vancomycin
Resistance in Staphylococcus. aureus. J Clin Microbiol. 2003 ; 41:5-14
Cutting K, Harding K. Criteria for identifying wound infection. J Wound Care. 1994;
3: 198–201.
Dale JJ, Callam MJ, Ruckley CV. et al. Chronic ulcers of the leg: a study of prevalence
in a Scottish community. Health Bulletin.1983; 41: 310–4.
Bibligraphy
187
Daltrey DC, Rhodes B, Chattwood JG. Investigation into the microbial flora of
healing and non-healing decubitus ulcers. J. Clin. Pathol.1981; 34:701-705.
Dang CN, Prasad YD, Boulton AJM, et al. Methicillin-resistant Staphylococcus aureus
in the diabetic foot clinic: A worsening problem. Diabet Med 2003; 20(2): 159-161.
Daniels MC, Kansal P, Smith TM, et al. Glucose regulation of transforming factor
alpha expression is mediated by products of the hexosamine biosynthesis pathway.
Mol Endocrinol. 1993; 7: 1041-1048.
Danis RP, Bingaman DP, Jirousek M, et al. Inhibition of intraocular
neovascularization caused by retina ischemia in pigs by PKC beta inhibition with
LY333531. Ophthalmol Vis Sci.1998; 39: 171-179.
Datta N and Kontomichalou P. Penicillinase synthesis controlled by infectious R
factors in Enterobacteriaceae. Nature.1965; 208: 239–241.
Davidson J. Growth factors in wound healing. Wounds.1995;7(a): 53A-64A.
Davies CE, Hill K E, Wilson M J. et al. Use of 16S ribosomal DNA PCR and
denaturing gradient gel electrophoresis for analysis of the microfloras of heating
and nonheating chronic venous leg ulcers. Journal of Clinical Microbiology. 2004;
42: 3549–57.
Davies CE, Wilson MJ, Hill KE. et al. Use of molecular techniques to study microbial
diversity in the skin: chronic wounds reevaluated. Wound Repair and Regeneration.
2001; 9: 332–40.
Davies CE. The comprehensive analysis of the microbial community of clinically
non-infected chronic venous leg ulcers. PhD thesis. Department of Oral Surgery,
Medicine and Pathology, University of Wales College of Medicine, Cardiff, UK. 2003.
Day MR, Armstrong DG. Factors associated with methicillin resistance in diabetic
foot infections. J Foot Ankle Surg 1997; 36: 322–5.
DCCT Research Group. The effect of intensive treatment of diabetes on the
development and progression of long-term complications in insulin-dependent
diabetes mellitus. N Engl J Med. 1003; 329:977-986.
De Sonnaville III, Colly LP, Wijkel D, et al. The prevalence and determinants of foot
ulceration in type 2 diabetic patients in primary health care setting. Diab Res Clin
Pract 1997; 35: 149-156
Delamaire M, Maugendre D, Moreno M, et al. Impaired leukocyte function in
diabetic patients. Diabet Med. 1997; 14: 29-34.
Bibligraphy
188
Delbridge L, Ctercteko G, Fowler C. et al. The aetiology of diabetic neuropathic
ulceration of the foot. British J Surgery. 1985; 72:1-6.
Delbridge L, Ellis CS, Robertson K, et al. Nonenzymatic glycosylation of keratin
from the stratum corneum of the diabetic foot. British J Dermatol. 1985; 112: 547-
554.
Delbridge L, Perry P, Marr S, et al. Limited joint mobility in the diabetic foot:
relationship to neuropathic ulceration. Diabetic Medicine. 1988; 5: 333-337.
Deo SS, Zantye A, Mokal R, e t a l . To identify the risk factors for high
prevalence of diabetes and impaired glucose tolerance in Indian rural
population. Int J Diab Dev Ctries 2006; 26: 19-23.
Devillers A, Garin E, Polard JL, et al. Comparison of Tc-99m-labelled antileukocyte
fragment Fab’ and Tc-99m- HMPAO leukocyte scintigraphy in the diagnosis of bone
and joint infections: a prospective study. Nucl Med Commun.2000; 21: 747–753.
Devillers A, Moisan A, Hennion F, et al. Contribution of technetium-99m
hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis
of diabetic foot infection. Eur J Nucl Med.1998; 25:132–138.
Diabetes Atlas. 3rd Ed., International Diabetes Federation. 2007.
Diamantopoulos EJ, Haritos D, Yfandi G, et al. Management and outcome of severe
diabetic foot infections. Exp. Clin. Endocrinol. Diabetes. 1998; 106: 346-352.
DiPiro JT, Cue JI. Single-agent versus combination antibiotic therapy in the
management of intra-abdominal infections. Pharmacotherapy 1994; 14:266–72.
Donnelly R, Emslie-Smith AM, Gardner ID, et al. Vascular Complications of. diabetes
BMJ 2000; 15;320(7241):1062-6.
Douglas WS & Simpson NB. Guidelines for the management of chronic venous leg
ulceration. Report of a multidisciplinary workshop. British Journal of Dermatology.
1995; 132: 446–52.
Dow G, Browne A, Sibbald RG. Infection in chronic wounds: controversies in
diagnosis and treatment. Ostomy/Wound . 1999; 45: 23–40.
Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds
using Pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC
Microbiology, 2008; 8: 43.
Dowzicky M, Talbot GH, Feger C, ET AL. Characterization of isolates associated
with emerging resistance to quinupristin/dalfopristin (Synercid®) during a
worldwide clinical program. Diagn Microb Infect Dis. 2000; 37:57-62.
Bibligraphy
189
Du Bois SK, Marriott MS and Amyes SG. TEM- and SHV-derived extended-
spectrum beta-lactamases: relationship between selec- tion, structure and
function. J. Antimicrob. Chemother. 1995; 35: 7–22.
Dupeyron C, Campillo B, Richardet JP, et al. Long-term efficacy of mupirocin in the
prevention of infections with meticillin-resistant Staphylococcus aureus in a
gastroenterology unit. J Hosp Infec. 2006; 63: 385-392.
Dutour C, Bonnet R, Marchandin H, et al. CTX-M-1, CTX-M-3, and CTX-M-14 beta-
lactamases from Enterobacteriaceae isolated in France. Antimicrob. Agents
Chemother. 2002; 46:534–537.
Dyck PJ, Karnes J, O’Brien PC. Diagnosis, Staging and classification of diabetic
neuropathy and association with other complications. In Dyck PJ. Thomas PK,
Asbury AK et al (eds). Diabetic Neuropathy. Philadelphia: WB Saunders. 1987: 36-
44.
Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various
types of diabetic neuropathy, retinopathy and nephropathy in a population based
cohort: The Rochester Diabetic Neuropathy Study. Neurology.1993; 43:817-824.
Dyck PJ. Detection, characterization and Staging of polyneuropathy: Assessed in
Diabetics. Muscle Nerve.1988; 11:21-32.
Eady EA, Cove JH. Staphylococcal resistance revisited: community acquired
methicillin resistant Staphylococcus aureus in infected and uninfected diabetic foot
ulcers. Clin Microbiol Infect 2006; 12 (2): 186-189.
Eady EA, Cove JH. Staphylococcal resistance revisited: community acquired
methicillin-resistant Staphylococcus. aureus an emerging problem for the
management of skin and soft tissue infections. Curr Opin Infect Dis. 2003; 16:103–
24.
Ebskov LB. Diabetic amputation and long term survival. Int.J. Rehab.Res.1998;
2:403-408.
Edmiston CE, Krepel CJ , Seabrook GR, et al. In vitro activities of moxifloxacin
against 900 aerobic and anaerobic surgical isolates from patients with intra-
abdominal and diabetic foot infections. Antimicrob Agents Chemother. 2004; 48(3):
1012-1016.
Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg. 2004;
187:25S–28S.
Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot:
The role of a specialized foot clinic. Q J Med. 1986; 60(232):763-771.
Bibligraphy
190
Edmonds ME, Foster AVM, Saunders EJ. Stage 2: The high risk foot In: A practical
Manual of Diabetic Foot care. Blackwell Publishing. 2006 ; 45 (Sep/Oct): 5.
Edmonds ME. Early use of antibiotics should not be ruled out. Diabetic Foot. 1999;
2: 135–8.
Edmonds ME. The diabetic foot: pathophysiology and treatment. Clinical
Endocrinological Metabolism. 1986; 15:889-916.
Ehrlich GD, Hu FZ, Shen K, et al. Bacterial plurality as a general mechanism driving
persistence in chronic infections. Clin Ortho Reled Res 2005; 437: 20-24.
Elhadd TA, Robb R, Jung RT, et al. Pilot study of prevalence of asymptomatic
peripheral arterial occlusive disease in patients with diabetes attending a hospital
clinic. Practical Diabetes Int. 1999; 16: 163– 6.
El-Tahawy AT. Bacteriology of diabetic foot. Saudi Med J. 2000; 21: 344–7.
Eneroth M, Apleqvist J, Stenstrom A. Clinical characteristics and outcome in 223
diabetic foot infections. Foot Ankle Int.1997; 18:716-722.
Espeland MA, Regensteiner JG, Jaramillo SA, et al. Measurement characteristics of
the ankle-brachial index: results from Action for Health in Diabetes Study. Vasc Med
2008; 13(3):225–33.
Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications
for routine laboratory testing. Clinical Microbiological Reviews. 2006; 19(1):165-
256.
European Antimicrobial Resistance Surveillance System. Annual Report. On-
going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis.
Bilthoven EARSS. 2002.
Faglia E, Caravaggi C, Marchetti R, et al. SCAR (SCreening for ARteriopathy) Study
Group. Diabet Med 2005; 22(10):1310–4.
Faglia E, Favales F, Quarantiello A, et al. Angiographic evaluation of peripheral
arterial occlusive disease and its role as a prognostic determinant for major
amputation in diabetic subjects with foot ulcers. Diabetes Care. 1998; 21: 625–30.
Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North
American children and adolescents: an epidemiologic review and a public health
perspective. J Pediatr 2000;136: 664–672.
Fawley WN, Parnell P, Hall J, et al. Surveillance for mupirocin resistance following
introduction of routine peri-operative prophylaxis with nasal mupirocin. J Hosp
Infect 2006; 62: 327-332.
Bibligraphy
191
Federman DG, Trent JT, Froelich CW, et al. Epidemiology of peripheral vascular
disease: a predictor of systemic vascular disease. Ostomy Wound Manage 1998;
44:58–62.
Feener EP, Xia P, Inoguchi T, et al. Role of protein kinase C in glucose and
angiotensin II induced plasminogen activator inhibitor expression. Contrib Nephrol.
1996; 118: 180-187
Feldman EL, Russell JW, Sullivan KA, et al. New insights into the pathogenesis of
diabetic neuropathy. Curr Opin Neurol. 1999; 5:553–563.
Fernando DJS, Masson EA, Veves A, et al. Relationship of limited joint mobility to
abnormal foot pressures and diabetic foot ulceration. Diab Care. 1991; 14: 8-11.
Fieter J, Daniel D, Davis C. The fetid foot: lower extremity infections in patients
with diabetes mellitus. Rev Infect Dis. 1979; 1:210-217.
Fiett, J, Palucha A, Miaczynska B, et al. novel complex mutant beta-lactamase, TEM-
68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-
spectrum beta-lactamase-producing Klebsiellae. Antimicrob. Agents Chemother.
2000; 44: 1499–1505.
Fischel RS, Barbul A, Beschorner WE, et al. Lymphocyte participation in wound
healing: Morphological assessment using monoclonal antibodies. Ann Surg 1987;
206: 25-29.
Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: a role for the
microcirculation? Diabetic Med. 1992; 8: 320-329.
Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
Forrest RD, Gamborg-Neilsen P. Wound assessment in clinical practice: a critical
review of methods and their application. Acta Med Scand. 1984; 687: 69–74.
Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study; prevalence of
symptomatic and symptomatic peripheral artery disease in the general population.
Int J Epidemiol 1991; 20: 384–92.
Freeman R. Human studies of recombinant human nerve growth factor and
diabetic peripheral neuropathy. Eur Neurol 1999; 41(suppl I): 20-26.
Friedman EA. Advanced glycosylated end products and hyperglycemia in the
pathogenesis of diabetic complications. Diabetes Care. 1991; 22 (Suppl 2): B65-B71.
Frykberg RG and Veves A. Diabetic foot infections. Diabetes/Metab. Rev.1996; 12:
255-270.
Bibligraphy
192
Frykberg RG. Team approach toward lower extremity amputation prevention in
diabetes. J. Am. Podiatr. Med. Assoc. 1997; 87: 305 ;312.
Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical
practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg.
2000; 39(5 suppl):S1-60.
Frykberg RG, Habershaw GM, Chrzan JS. Epidemiology of the diabetic foot:
ulcerations and amputations. In: Contemporary Endocrinology: Clinical
Management of Diabetic Neuropathy. edited by Veves A, Humana Press, Totowa,
NJ,1998: 273.
Frykberg RG, Larvey L, Pham H, et al. Role of neuropathy and high foot pressures
in diabetic foot ulceration. Diabetes Care. 1998; 21: 1714-1719.
Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic Foot Disorders: A Clinical
Practice Guideline. Journal Foot and Ankle Surgery. 2006; 45: S52.
Frykberg RG. Biomechanical considerations of the diabetic foot. Lower Extremity.
1995; 2: 297-214.
Frykberg RG. Diabetic Foot ulcerations. In: the High Risk Foot in Diabetes Mellitus,
edited by R.G.Frykberg, Churchill Living stone, New York, 1991; 151.
Frykberg RG. Diabetic foot ulcers: Current concepts. J. Foot Ankle Surg. 1998; 37:
440-446.
Frykberg RG. Epidemiology of the diabetic foot: ulcerations and amputations. Adv.
Wound Care. 1999; 12: 139-141.
Fumal I, Branham C, Paquet P, et al. The beneficial toxicity paradox of
antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-
concept study. Dermatology 2002; 204: 70–4.
Gadepalli R, Dhawan B, Sreenivas V, et al. A clinico-microbiological study of
diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;
29:1727-1732
Gales Ac, Jones RN, Pfaller MA, et al. Two-year assessment of the pathogen
frequency and antimicrobial resistance patterns among organisms isolated from
skin and soft tissue infections in Latin American Hospitals: results from the SENTRY
antimicrobial surveillance program, 1997–1998. SENTRY Study Group. Int J Infect
Dis. 2000; 4:75-84.
Bibligraphy
193
Gardner SE, Frantz RA & Doebbeling BN. The validity of the clinical signs and
symptoms used to identify localized chronic wound infection. Wound Repair and
Regeneration. 2001; 9: 178–86.
Gatling W, Houston AC, Hill RD. An epidemiological survey – the prevalence of
diabetes mellitus in a typical English Community. J Roy Coll Phys London. 1985; 4:
248-50.
Gavin JR III, Alberti KGMM, Davidson MB, et al. Report of the Expert Committee on
the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183–
1197.
Ge Y, MacDonald D, Hait H, et al. Microbiological profile of infected diabetic foot
ulcers. Diabet Med. 2002; 19: 1032–4.
Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes
mellitus. Diabetes Care 2003; 26:3160-3167.
Gerding DN. Foot infections in diabetic patients: the risk of anaerobes. Clin Infect
Dis. 1995; 20 (suppl): S283–8.
Geyid A and Lemeneh Y. The incidence of methicillin-resistant Staphylococcus
aureus strains in clinical specimens in relation to their β-lactamase producing and
multiple drug resistance properties in Addis Ababa. Ethiop Med J. 1991; 29: 149-
161.
Gibbons GW and Eliopoulos GM. Infection of the diabetic foot. Management of
Diabetic Foot Problems. Kozak GP, Jr Hoar CS, Rowbottam JL, editors Philadelphia:
Saunders. 1984:97–102.
Gibbs RC and Boxer MC. Abnormal biomechanics of feet and their cause of
hyperkeratoses. Journal of American Academy of Dermatology 1982; 6:1061-1069.
Gilchrist B and Reed C. The bacteriology of chronic venous ulcers treated with
occlusive hydrocolloid dressings. British Journal of Dermatology. 1989; 121: 337–
44.
Gilliland EL, Nathwani N, Dore CJ, et al. Bacterial colonisation of leg ulcers and its
effect on the success rate of skin grafting. Ann. R. Coll. Surg. Engl. 1988; 70: 105-
108.
Gin H. Infection and diabetes [in French]. Rev Med Interne. 1993; 14: 32–8.
Gleckman RA, Al-Wawi M. A review of selective infections in adult diabetic. Compr
Ther. 1999; 25: 109-113.
Bibligraphy
194
Gniadkowski M, Schneider I, Palucha A, et al. Cefotaxime-resistant
Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a
new CTX-M-3 ce- fotaxime-hydrolyzing beta-lactamase that is closely related to the
CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 1998; 42: 827–832.
Goldfarb S, Zihadeh FN, Kern EFO, et al. Effects of polyol pathwayinhibition and
dietary myo-inositol on glomerular hemodynamic function in experimental
diabetes mellitus in rats. Diabetes. 1991; 40:465-471.
Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot infections: bacteriology and
activity of 10 oral antimicrobial agents against bacteria isolated from consecutive
cases. Diabetes Care. 1996; 19: 638–41.
González RG, Barnett P, Aguayo J, et al. Direct measurement of polyol pathway
activity in the ocular lens. Diabetes. 1984; 33: 196-199
Grant DS, Kleimann HK, Goldberg ID, et al. Scatter factor induces blood vessel
formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941.
Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers.
JAMA. 1995; 27:721–3.
Grayson ML. Diabetic foot infections: antimicrobial therapy. Infect Dis Clin North
Am. 1995; 9:143–61.
Greenbaum CJ, Cuthbertson D, Eisenbarth GS, et al. Islet cell antibody positive
relatives with HLA-DQA1*0102, DQB1*0602: identification by the Diabetes
Prevention Trial-1. J Clin Endocrinol Metab 2000; 85:1255–1260.
Greenberg RN, Newman MT, et al. Ciprofloxacin, lomefloxacin or levofloxacin as
treatment as treatment from chronic osteomyelitis. Antimicrob Agents Chemother
2000, 44(1): 164-166.
Greene DA, Lattimer SA. The polyol pathways in dysfunction of diabetic peripheral
nerve. Diabet Med 1985; 2:206-210.
Grenon SM, Gagnon J, Hsiang Y. Ankle-brachial index fr assessment of peripheral
arterial disease. N Engl J Med 2009; 361(e40):1–3.
Grim SA, Rapp RP, Martin CA, et al. Trimethoprim-Sulfamethoxazole as a Viable
Treatment Option for Infections Caused by Methicillin-Resistant Staphylococcus
aureus. Pharmacotherapy. 2005; 25(2): 253-264.
Gu J, Li H, Li M, et al. Bacterial insertion sequence IS256 as a potential molecular
marker to discriminate invasive strains from commensal strains of Staphylococcus
epidermidis. J. Hosp. Infect. 2005; 61: 342-348.
Bibligraphy
195
Gulliford MC, Mahabir D. Diabetic foot disease in a Carribbean community. Diabet
Res Clin Pract. 2003; 56; 35-40.
Gupta A, Gupta R, Sarna M, et al. Prevalence of diabetes, impaired fasting
glucose and insulin resistance syndrome in an urban Indian population.
Diabetes Res Clin Pract 2003; 61: 69-76.
Haitoglou CS, Tsilbary EC, Brownie M, et al. Altered cellular interactions between
endothelial cells and nonenzymatically glycosylated laminin / type IV collagen . J
Biol Chem. 1992; 267: 12404-2407.
Halbert AR, Stacey MC, Rohr JB, et al.. The effect of bacterial colonisation on venous
ulcer healing. Australas. J. Dermatol. 1992; 33:75-80.
Hales CN, Barker DJP. The thrifty phenotype hypothesis. British MedicalBulletin.
2001; 60:5-20
Haltmayer M, Mueller T, Horvath W, et al. Impact of atherosclerotic risk factors on
the anatomical distribution of peripheral arterial disease. Int Angiol. 2001; 20: 200
–7.
Hamalainen H, Ronnemma T, Halonen JP, et al. Factors predicting lower extremity
amputations in patients with type 1 or type 2 diabetes mellitus: A population-based
7 year follow-up study. J Int Med 1999; 246:97-103.
Hampton G, Birke IA. Treatment of wounds caused by pressure and insensitivity.
In: Kloth LC, MeCulloch iM, Feeder iA (eds). Wound healing: alternatives in
management. Davis, Philadelphia 1990: 196-220.
Hanifah YA, Hiramatsu K, Yokota T. Characterization of methicillin-resistant
StaphylococcuS. aureus associated with nosocomial infection in the University
Hospital, Kuala Lumpur. J Hosp Infect. 1992; 21: 15-28.
Hansson C, Hoborn J, Möller A. et al. The microbial flora in venous leg ulcers
without clinical signs of infection. Acta Dermato-Venereologica. 1995; 75: 24–30.
Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes
Care. 1998; 21(Suppl. 3):C11-C14.
Harrison CJ :Quinupristin/dalfopristin. Semin Pediatr Infect Dis. 2001; 12:200-210.
Hart GW. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins.
Annu Rev Biochem. 1997; 66: 315-335.
Hartemann-Heurtier A, Robert J, Jacqueminet S, et al. Diabetic foot ulcer and
multidrug-resistant organisms: risk factors and impact. Diabet Med. 2004; 21: 710–
5.
Bibligraphy
196
Harvey J, Cohen MM. Technetium-99- labeled leukocytes in diagnosing diabetic
osteomyelitis in the foot. J Foot Ankle Surg. 1997; 36: 209 –214.
Haslbeck KM, Schleicher E, Bierhaus A et al. The AGE/RAGE/NF-(kappa) B
pathwaymay contribute to the pathogenesis of polyneuropathy in impaired glucose
tolerance (IGT). Exp Clin Endocrinol Diabetes 2005; 113(5):288-291.
Hata Y, Rook SL, Aiello LP. Basic fibroblast growth factor induces expression of
VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated
protein kinase-dependant pathway. Diabetes 1999; 48: 1145-1155.
Hau T, Ahrenholz DH, Simmons RL. Secondary bacterial peritonitis: the biologic
basis of treatment. Curr Probl Surg 1979; 16:1–65.
Heald AH, O’Halloram DJ, Richards et al. fungal infection of the diabetic foot: two
distinct sysndromes. Diabetic Medicine 2001; 18: 567-572.
Hennis AJJ, Fraser HS, Jonnalagadda R, et al. Explainations for the high risk of
diabetes-related amputation in a Carribean population of black African descent and
potential for prevention. Diab Care 2004; 27(11):2636-2641.
Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid resistant, vancomycin-
resistant Enterococcus faecium. N Engl J Med. 2002; 346: 867-869.
Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant
recipients. Clin Infect Dis 1994;19: S33.
Hirschl M, Hirschl AM. bacterial flora in mal perforant and antimicrobial treatment
with ceftriaxone. Chemotherapy. 1992; 38:275–80.
Ho Jl, Barza M. Role of aminoglycoside antibiotics in the treatment of intra-
abdominal infection. Antimicrob Agents Chemother 1987 ;31:485–91.
Hoban DJ, Biedenbach DJ, Mutnick AH, et al. Pathogen of occurrence and
susceptibility patterns associated with pneumonia in hospitalized patients in North
America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn.
2003; 45:279-285.
Holewski ii, Stess RM, Graf PM, et al. Aesthesiometry: quantification of cutaneous
pressure sensation in diabetic peripheral neuropathy. Journal of Rehabilitation
Residual Development. 1988; 25: 1-10.
Holten KB, Onusko EM. Appropriate prescribing of oral beta-lactam antibiotics.
American Family Physician 2000; 62 (3): 611–20.
Honing ML, Morrison PJ, Banga JD, et al. Nitric oxide availability in diabetes
mellitus. Diabetes Metab Rev 14:241-249, 1998.
Bibligraphy
197
Huang ZM, Mao PH, Chen Y, et al. Study on the molecular epidemiology of SHV
type beta-lactamase-encoding genes of multiple-drug-resistant Acinetobacter
baumannii. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25:425–427.
Hubner G, Braucle M, Smola H, et al. Differential regulation of pro-inflammatory
cytokimes during wound healing in normal and glucocorticoid-treated mice.
Cytokine 1996; 8: 548-556.
Humphrey A, Palumbo P, Butters M, et al. The contribution of non-insulin
dependant diabetes to lower extremity amputation in the community. Arch Intern
Med 1994; 154:885-892.
Humphrey ARG, Dowse GK, Thomas K, et al. Diabetes and nontraumatic lower
extremity amputations: incidence, risk factors and prevention: 12-year follow- up
study in Nauru. Diabetes Care. 1996; 19:710–714.
Humphrey LL, Palumbo PJ, Butters MA, et al. The contribution of non-insulin
dependent diabetes to lower extremity amputation in the community . Arch. Intern.
Med.1994; 154:885-892.
Hunt JA. Foot infections in diabetes are rarely due to a single microorganism.
Diabet Med. 1992; 9:749–52.
Hunt TK, La Van FB. Enhancement of wound healing by growth factors. N Engl J
Med 1989, 321: 111-112.
Hutchinson A, McIntosh A, Feder G, et al. Clinical Guidelines and Evidence Review
for Type 2 Diabetes: Prevention and Management of Foot Problems, 2. Royal
College of General Practitioners, London, UK. 2000.
Inoguchi T, Xia P, et al. Insulin’s effect on protein kinase C and diacylglycerol
induced by diabetes and glucose in vascular tissues. Am J Physiol. 1994; 267(3 Pt
1): E369-E379.
International Diabetes Federation, Diabetes Atlas, 2nd ed., International
Diabetes Federation, Brussels, 2003.
International Diabetes Federation, Diabetes Atlas, 3rd ed., International Diabetes
Federation, Brussels, 2006.
International Diabetes Federation: Diabetes Atlas 2000. Brussels, International
Diabetes Federation, 2000.
International Working Group on the Diabetic Foot. International Consensus on
the Diabetic Foot, Amsterdam, The Netherlands, 1999.
Bibligraphy
198
Ishii H, Jirousek MR, Koya D, et al: Amelioration of vascular dysfunction in diabetic
rats by an oral PKC beta inhibitor. Science. 1996; 272:728-731.
Jackson LA. Evaluating diabetes mellitus as a risk factor for community-acquired
infections. Clin Infect Dis 2005; 41(3): 289-290.
Jacoby GA, Medeiros AA, O’Brien TF, et al. Broad-spectrum, transmissible beta-
lactamases. N. Engl. J. Med. 1988; 319: 723–724.
Jacoby GA, Medeiros AA. More extended-spectrum beta- lactamases. Antimicrob.
Agents Chemother 1991; 35:1697–1704.
Jacoby GA, Munoz Price LS. The new β lactamases. N Engl J Med. 2005; 355:380-
391.
Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing
resistance to oxyimino-beta-lactams. Infect. Dis. Clin. N. Am. 1997; 11:875–887.
Jaegebald G, Apelqvist J, Nyberg P, Berger B. The diabetic foot: From ulcer to
multidisciplinary team approach . A process analysis. In abstract of the 3rd
International symposium on the Diabetic foot, Noordwijkerhout, The Netherlands,
May 6, 1998, Abstract :87,149.
Jaeger C, Allendorfer J, Hatziagelaki E. et al. Persistant GAD 65 antibodies in
longstanding IDDM not associated with residual beta-cell function, neuropathy or
HLA-DR status. Horm Metab Res 1997; 29: 510-515.
Jager A, Kostense PJ, Ruhe HG, et al. Microalbuminuria and peripheral arterial
disease are independent predictors of cardiovascular and all-cause mortality,
especially among hypertensive subjects: five-year follow-up of the Hoorn Study.
Arterioscler Thromb Vasc Biol 1999; 19:617– 624.
Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin
North Am. 2004; 88: 1001-1036.
Jeffcoate WJ & Harding KG. Diabetic foot ulcers. Lancet 2003; 361: 1545–51.
Jeffcoate WJ, Macfarlane RM, Fletcher EM: The description and classification of
diabetic foot lesions. Diabet Med. 1993; 10: 676 – 679.
Jeffcoate WJ. The incidence of amputation in diabetes. Acta Chir Beig. 2005; 105:
140-144.
Jeffcoate WJ. Use of antibiotics in uninfected ulcers may do more harm than good.
Diabetic Foot 1999; 2: 132–5.
Johnson PC, Beggs JL. Pathology of the autonomic nerve innervating the vasa
nervorum in diabetic neuropathy. Diabet Med 1993; 10 (suppl 2): S56-61.
Bibligraphy
199
Johnson PG, Oseroff AR. Electrically enhanced percutaneous delivery of delta-
aminolevulinic acid using electric pulses and DC potential. Photochemistry and
Photobiology 2002; 75: 534–540.
Johnson S, Lebahn F, Peterson LR, et al. Use of an anaerobic collection and
transport swab device to recover anaerobic bacteria from infected foot ulcers in
diabetics. Clin. Infect. Dis. 1995; 20 (Suppl. 2):S289-S290
Jones EW, Edwards R, Finch R, et al. A microbiological study of diabetic foot lesions.
Diabet Med. 1985; 2:213–5.
Jones EW, Peacock I, McLain S, et al. A clinicopathological study of diabetic foot
ulcers. Diabet Med. 1987; 4:475 -479.
Jonnalagadda S, Veerabagu MP, Rakela J, et al. Candida albicans osteomyelitis in a
liver transplant recipient: a case report and review of the literature.
Transplantation 1996; 62: 1182—1184.
Joseph WS, Axler DA. Microbiology and antimicrobial therapy of diabetic foot
infections. Clin Podiatr Med Surg. 1990; 7: 467–81.
Joshi N, Caputo G, Weitekamp M, et al. Infections in patients with diabetes mellitus.
N Engl J Med. 1999; 341: 1906–12.
Jude EB, Boulton AJM. End stage complications of diabetic neuropathy . Diabet Rev.
1999; 7:395-410.
Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and
nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;
24: 1433–7.
Kaiser N, Feener EP, Baoukobza-Vardi N, et al: Differential regulation of glucose
transport and transporters by glucose in vascular endothelial and smooth muscle
cells. Diabetes. 1993; 42: 80-89.
Kalani M, Brismar K, Fagrell B, et al. Transcutaneous oxygen tension and toe blood
pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999; 22:
147-151.
Kannel WB, D’Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of
cardiovascular disease: the Framingham experience. Am Heart J 1990; 120: 672–
676.
Kannel WB, McGee DL. Update on some epidemiologic features of intermittent
claudication: the Framingham study. J Am Geriatr Soc. 1985; 33: 13– 8.
Bibligraphy
200
Karanfilian RG, Lynch TG, Zirul VT, et al. The value of laser Doppler Velocimetry
and transcutaneous oxygen tension determination in predicting healing of ischemic
forefoot ulcerations and amputations in diabetic and nondiabetic patients. J. Vasc .
Surg. 1986; 4: 511-516.
Karchmer AW. Mandell GL, Bennett JE, et al. Principles and Practice of Infectious
Diseases, 4th ed. New York: Curchill Livingstone, 1995: 247–64.
Kastenbauer T, Sauseng S, Sokol G, et al. A prospective study of predictors for foot
ulcerations in type 2 diabetes. J American Podiat Med Assoc 2001; 91(7):343-350.
Katsilambros NL, Tsapogas PC, Arvanitis MP, et al. Risk factors for lower-extremity
arterial disease in non-insulin-dependent diabetic persons. Diabet Med 1996;
13:243–246.
Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J
Pediatr Endocrinol Metab 2002;15[Suppl 2]:737–744.
Kaufman J, Breeding L, Rosenberg N. Anatomical location of acute diabetic foot
infection: its influence on the outcome of treatment. Am Surg. 1987; 53:109 -112.
Kavi J, Andrews JM, Wise R. Mupirocin-resistant Staphylococcus aureus. Lancet.
1987; 2: 1472.
Kayser FH. The quinolones: mode of action and mechanism of resistance. Res Clinic
Forums. 1985; 7: 17-27.
Kesah C, Ben Redjeb S, Odugbemi TO, et al.Prevalence of methicillin-resistant
StaphylococcuS. aureus in eight African hospitals and Malta. Clin Microbiol Infect.
2000; 9:153-156.
Khan CR, Weir GC, eds. Joslin’s diabetes mellitus, 13th ed. Media: Williams &
Wilking, 1994.
King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence,
numerical estimates and projections, Diabetes Care 1998; 21 (9):1414–1431.
King H, Rewers M. Global estimates for prevalence of diabetes mellitus and
impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group.
Diabetes Care 1993;16: 157–177.
Kingsley A. A proactive approach to wound infection. Nursing Standard 2001; 15:
50–8.
Kingsley A. The wound infection continuum and its application to clinical practice.
Ostomy Wound Manage. 2003; 49: 1–7.
Bibligraphy
201
Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic
retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is
less than 30 years. Arch Ophthalmol 1984; 102: 520-536.
Knighton DR, Ciresi KF, Fiegel VD, et al. Classification and treatment of chronic
nonhealing wounds: successful treatment with autologous platelet-derived wound
healing factors (PDWHF). Ann Surg. 1986; 204: 332–330.
Knighton DR, Fiegel VD. Macrophages-derived growth factors in wound healing:
Regualtion of growth factor production in the oxygen microenvironment. An Rev
Respir Dis 1989; 140: 1108-1111.
Knighton DR, Hunt TK, Scheuenstuhl H, et al. Oxygen tension regulates expression
of angiogenesis factor by macrophages. Science 1983; 221: 1283-1285.
Knothe H, Shah P, Krcmery V, et al. Transferable resistance to cefotaxime, cefoxitin,
cefamandole and cefu- roxime in clinical isolates of Klebsiella pneumoniae and
Serratia marcescens. Infection 1983; 11: 315–317.
Kolm-Litty V, Sauer U, Nerlich A, et al. High glucose induced transforming growth
factor beta-1 production is mediated by the hexosamine pathway in porcine
glomerular mesangial cells. J Clin Invest. 1998; 101: 160-169.
Kontiainen S, Rinne, E. Bacteria in ulcera crurum. Acta Dermato-Venereologica
1988; 68: 240–4.
Kornitzer M, Dramaix M, Sobolski J, et al. Ankle/arm pressure index in
asymptomatic middle-aged males: an independent predictor of ten-year coronary
heart disease mortality. Angiology 1995; 46:211–219.
Koya D, King GL: Protein Kinase C activation and the development of diabetic
complications. Diabetes. 1998 ; 47: 859-866.
Kravos A, Bunic-Sotosek K. Ankle-brachial index screening for peripheral artery
disease in asymptomatic patients between 50 and 70 years of age. J Int Med Res
2009; 37(5):1611–9.
Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric
oxide synthase gene expression in endothelial cells and in vivo: a specific vascular
action of insulin. Circulation. 2000; 101: 676-681.
Kuehnert MJ, Hill HA, Kupronis BA, et al. Methicillin-resistant-Staphylococcus
S.aureus hospitalizations, United States.
Bibligraphy
202
Kullo IJ, Bailey KR, Kardia SL, et al. Ethnic differences in peripheral arterial disease
in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc
Med. 2003; 8: 237– 42.
Kumar S, Ashe HA, Parnell LN, et al. The prevalence of foot ulceration and its
correlates in type 2 diabetic patients: a population-based study. Diabet. Med. 1994;
11: 480–484.
Kurkinen M, Vaheri A, Roberts PJ, Stenmans S. Sequential appearance of
fibronectin and collagen in experimental granulation tissue. Lab Invest 1980; 43:
47-51.
Lai CS, Lin SD, Chou CK, Lin HJ. Aspergillosis complicating the grafted skin and free
muscle flap in a diabetic. Plast. Reconstr. Surg. 1993; 92 (3): 532-536.
Lander HM, Tauras JM, Ogiste JS, et al. Activation of the receptor for advanced
glycation end products triggers a MAP kinase pathway regulated by oxidant stress.
Journal of Biological Chemistry. 1997; 272, 17810–17814.
Lane PH, Steffes MW, Fioretto P, et al. Renal expansion in insulin dependent
diabetes mellitus. Kidney Int 1993; 43:661-667
Larsson J, Agardh CD, Apleqvtis J, et al. longterm prognosis after healed amputation
in patients with diabetes. Clin Orthop. 1998; 350: 149-158.
Larsson J, Apleqvist J, Agardh CD, et al. Decreasing incidence of major amputation
in diabetic patients: a consequence of a multidisciplinary foot care team approach?
Diabetic Med. 1995; 12: 770-776.
Larvay LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome: evaluating
the prevalence and incidence of foot pathology in Mexican Americans and non
Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;
26: 1435-1438.
Larvey LA, Armstrong DG, Vela S, et al. Practical criteria for screening patients at
high risk for diabetic foot ulceration. Arch. Intern. Med. 1998; 158: 157-162.
Larvey LA, Ashry HR, Van Houtum W, et al. Variation in the incidence and
proportion of diabetes-related amputations in minorities. Diabetes Care. 1996; 19:
48-52.
Lautenbach E, Patel JB, Bilker WB, et al Extended-spectrum β-lactamase-producing
Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of
resistance on outcomes. Clin Infect Dis. 2001; 32:1162-1171.
Bibligraphy
203
Lavery LA, Armstrong DG, Harkless LB: Classification of diabetic foot wounds. J
Foot Ankle Surg. 1996; 35: 528-531.
Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infection in
person with diabetes. Diabetes Care 2006; 6: 1288-1293.
Lavery LA, Harkless LB, Felfer-Johnson K, Mundine S. Bacterial pathogens in
infected puncture wounds in adults with diabetes. J Foot Ankle Surg. 1994; 33: 91 -
7.
Lawrence JC, Lilly HA, Kidson A. Wound dressings and airborne dispersal of
bacteria. Lancet 1992: 339, 807.
Leavesly DI, Scharwtz MA, Rosenfeld M, et al. Integrin beta 1-and beta 3-mediated
endothelial cell migration is triggered through distinct signaling mechanism. J cell
Biol 1993; 12: 163-170.
Lee JS, Lu M, Lee VS, et al. Lower extremity amputation . Incidence, risk factors, and
mortality in the Oklahoma Indian Diabetes Study. Diabetes. 1993; 42: 876-882.
Lee SY, Kotapati S, Kuti JL, et al. Impact of extended-spectrum β-lactamase-
producing Escherichia coli and Klebsiella species on clinical outcomes and hospital
costs: a matched cohort study. Infect Control Hosp Epidemiol. 2006; 27: 1226-1232.
Legat FJ, Maier A, et al. Penetration of fosfomycin into inflammatory lesions in
patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother
2003; 47(1): 371-374.
Leggetter S, Chaturvedi N, Fuller JH, et al. Ethnicity and risk of diabetes-related
lower extremity amputation: A population based, case control study of African
Caribbeans and Europeans in the United Kingdom. Arch Intern Med 2002;
162(1):73-78.
Lehto S, Pyorala K, Ronnemaa T, et al. Risk fators predicting lower extremity
amputation in NIDDM. Diabetes Care 1996; 19(6):607-612.
Leibovich SJ, Ross R. the role of macrophage in wound repair: A study with
hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
Leid J. Human leukocytes adhere to, penetrate, and respond to Staphylococcus
aureus biofilms. Infection and Immunity 2002; 70:6339–6345.
Levin ME, O'Neal LW. Preface. In: Kevin and O'Neal (eds.) The Diabetic Foot, 3rd
edition. St_Louis: C.V. Mosby Co., 1983.
Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care. 1995;
10:1383-1394.
Bibligraphy
204
Levitt NS, Stansberry KB, Wychanck S, et al. Natural progression of autonomic
neuropathy and autonomic function tests in a cohort of IDDM. Diabetes Care. 1996;
19: 751-754.
Leymarie F, Richard JL, Malgrange D and on the behalf of the French Working
Group on the Diabetic Foot. Factors associated with diabetic patients at high-risk
for foot ulceration. Diabetes Metab. 2005; 31: 603–605.
Li XZ, Ma D, Livermore DM, et al. Role of efflux pump(s) in intrinsic resistance of
Pseudomonas aeruginosa: active efflux as a contributing factor to beta lactum
resistance. J Antimicrob Chemother 1994; 38: 1742–1752.
Lian Z, Tianjue Y. Role of outer membrane proteins in imipenem diffusion in
Pseudomonas aeruginosa. Chin Med Sci J 1999; 14: 57–60.
Lídia R, Domínguez MA, Neus R, et al. Relationship between clinical and
environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch Med
Res. 2004; 35: 251–257.
Lipsky BA, Itani K, Norden C. et al. Treating foot infections in diabetic patients: a
randomized, multicenter, open-label trial of linezolid versus ampicillin-
sulbactam/amoxicillin-clavulanate. Clinical Infectious Diseases. 2004; 38: 17–24.
Lipsky BA, Pecoraro RE, Larson SA, et al. Outpatient management of
uncomplicated lower-extremity infections in diabetic patients. Arch. Intern. Med.
1990; 150: 790-797.
Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot
infections. Clin. Infect. Dis. 2004; 39: 885-910.
Lipsky BA, McDonald D, Litka PA. Treatment of infected diabetic foot ulcers:
Topical MSI-78 vs. oral ofloxacin (abstract) Diabetologia 1997; 40(1): 482.
Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot: soft tissue and bone infection.
Infect Dis Clin North Am. 1990; 4: 409–32.
Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS
Immunol Med Microbiol. 1999; 26: 267–76.
Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin. Infect. Dis. 1997; 25:
1318-1326.
Litzelaman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity
clinical abnormalities in patients with non-insulin dependant diabetes mellitus: A
randomized, controlled trial. Ann Intern Med 1993; 19(1): 36-41.
Bibligraphy
205
Louie TJ, Bartlett JG, Tally FP, Gorbach SL. Aerobic and anaerobic bacteria in
diabetic foot ulcers. Ann Intern Med. 1976; 85:461-463.
Ma L, Ishii Y, Chang FY, et al. CTX-M-14, a plasmid-mediated CTX-M type extended-
spectrum beta-lac- tamase isolated from Escherichia coli. Antimicrob. Agents
Chemother. 2002; 46: 1985–1988.
MacFarlane DE, Baum KF and Serjeant GR. Bacteriology of sickle cell leg ulcers.
Trans. R. Soc. Trop. Med. Hyg. 1986; 80: 553-556.
Macgregor RR, Graziani AL, Samuels P. Randomized, doubleblind study of
cefotetan and cefoxitin in post-cesarean section endometritis. Am J Obstet Gynecol
1992; 167:139–43.
Mackie & McCartney. Practical Medical Microbiology. Fourteenth Edition.
Published by Churchill Livinstone 2007.
Madani TA, Al-Abdullah NA, Al-Sanousi AA, et al. Methicillin-resistant
StaphylococcuS. aureus in two tertiary-care centers in Jeddah, Saudi Arabia. Infect
Control Hosp Epidemiol. 2001; 22: 211-216.
Madsen SM, Westh H, Danielson L. et al. Bacterial colonization and healing of
venous leg ulcers. APMIS. 1996; 104: 895–F899.
Mah T, O’Toole G. Mechanisms of biofilm resistance to antimicrobial agents. Trends
in Microbiology 2001; 9: 34–39.
Maillard LC. Action des acides amines sur les sucres: formation des melaniodines
par voie methodique. C.R. Academy Sciences. 1912; 154: 66–68.
Margolis DJ, Allen-Taylor L, Hoffstad O, et al. Diabetic neuropathic foot ulcers and
amputation. Wound Repair Regen. 2005; 13: 230–236.
Margolis DJ, Allen-Taylor L, Hoffstad O, et al. Diabetic neuropathic foot ulcers: The
association of wound size, wound duration, and wound grade on wound healing.
Diabetes Care 2002; 25(10): 835-1839.
Margolis DJ, Bilker W, Santanna J. et al. Venous leg ulcer: incidence and prevalence
in the elderly. Journal of the American Academy of Dermatology 2002; 46: 381–386.
Margolis DJ, Kantor J, Santanna J, et al. Risk factors for delayed healing of
neuropathic diabetic foot ulcers: A pooled analysis. Arch Dermatol 2000;
136(12):1531-1535.
Martin C, Cotin A, Giraud A. Comparison of concentrations of sulbactam–ampicillin
administered by bolus injections or bolus plus continuous infusion in tissues of
Bibligraphy
206
patients undergoing colorectal surgery. Antimicrob Agents Chemother 1998;
42:1093–7.
Martin P. Wound healing: Aiming for perfect skin generation. Science 1997; 276:
75-81.
Mason BW, Howard AJ & Magee JT. Fusidic acid resistance in community isolates of
methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. Journal
of Antimicrobial Chemotherapy 2003; 51: 1033–6.
Masuda N, Saka GE, and Ohya S. Outer membrane proteins responsible for multiple
drug resistance in Pseudomonas aeruginosa, Antimicrob Agents Chemother. 1995;
39: 645–649.
Mathai D, Jones RN, Stilwell M, et al. 40th Intersci. Conf. Antimicrob. Agents
Chemother., abstr. 2000:1027.
Mathur P, Tatman A, Das B, et al. Prevalence of ESBL gram negative bacteria in a
tertiary care hospital. Indian J Med Microbiol 2002; 115:153-7.
Matsen FA, Wyss CR, Robertson CL, et al. The relationship of transcutaneous, pO2
and laser Doppler measurements in a human model of local arterial insufficiency.
Surg. Gynecol. Obstet. 1984; 159: 518-422.
Mayfield JA, Reiber GE, Nelson RG, et al. A foot risk classification system to predict
diabetic amputation in Pima Indians. Diabetes Care 1996; 19(7):704-709.
Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive foot care in people with
diabetes: technical review. Diabetes Care. 1998; 21: 2161-2177.
Mayo CH, Aphorisms of Dr Charles Horace Mayo, 1865-1939 and William James
Mayo, 1861-1939, Rochester, Mayo Foundation for Medical Education and
Research, 1988.
Mbanya JC, Sobngwi E: Diabetes in Africa. Diabetes microvascular and
macrovascular disease in Africa. J Cardiovasc Risk. 2003; 10: 97-102.
McClain DA, Paterson AJ, Roos MD, et al. Glucose and glucosamine regulate growth
factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA.
1992; 89: 8150-8154.
McIntyre EA, Walker M. Genetics of type 2 diabetes and insulin resistance:
knowledge from human studies. Clin Endocrinol. 2002; 57: 303-311.
McMahon BJ, Hennessy TW, Bensler JM. et al. The relationship among previous
antimicrobial use, antimicrobial resistance, and treatment outcomes for
Helicobacter pylori infections. Annals of Internal Medicine 2003; 139: 463–9.
Bibligraphy
207
McNeely MJ, Bokyo EJ. Diabetes related comorbitidies in Asian Americans: Results
of a National Health Survey. J Diabetes Complications 2005; 19(2):101-106.
McNeely MJ, Boyko E, Ahroni JH. The independent contributions of diabetic
neuropathy and vasculopathy in foot ulceration: How great are the risks? Diabetes
Care. 1995; 18: 216-219.
Mead P. Infections of the female pelvis. In: Mandell GL, Bennett JE, Dolin R, editors.
Principles and Practice of Infectious Diseases, 4th Edn. New York: Churchill
Livingstone, 1995:1090–1098.
Meggitt B: Surgical management of the diabetic foot. Br J Hosp Med. 1976; 1 6:227–
332.
Melton LJ, Macken KM, Palumbo PJ, et al. Incidence and prevalence of clinical
peripheral vascular disease in a population based cohort of diabetic patients.
Diabetes Care 1980; 3:650–654.
Melton LJ, Macken KM, Palumbo PJ, et al. Incidence and prevalence of peripheral
vascular disease in a population based cohort of diabetic patients. Diabetes Care.
1980; 3: 648-654.
Menon VU, Kumar KV, Gilchrist A, et al. Prevalence of known and undetected
diabetes and associated risk factors in central Kerala - ADEPS. Diabetes Res Clin
Pract 2006; 74: 289-94.
Mertz P. Cutaneous biofilms: friend or foe? Wounds, 2003; 15:129–132.
Mike E, Ali F. The use of antibiotics in the diabetic foot. Am J Surg. 2004; 187: 25S–
28S.
Miller DJ, Mejicano GC. Vertebral Osteomyelitis due to Candida Species: case report
and literature review. Clin Infect Dis 2001;33:523—30.
Missoni EM, RadeNaderal D, Chroma- togr SJ. Analyt. Technol. Biomed, Life Sci.
2005; 822 (1-2): 118-123.
Moland ES, Black JA, Hossain A, et al. Discovery of CTX-M-like extended-Spectrum
beta- lactamases in Escherichia coli isolates from five U.S. states. Antimicrob.
Agents Chemother. 2003; 47: 2382–2383.
Moland ES, Black JA, Ourada J, et al. Occurrence of newer beta-lactamases in
Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents
Chemother. 2002; 46: 3837–3842.
Morbach S, Lutalet JK, Viswanathan V, et.al. Regional differences in risk factors and
clinical presentation of diabetic foot lesions. Diabet Med. 2004; 21:91-95.
Bibligraphy
208
Morris AD, McAlpine R, Steinke D, et al. Diabetes and lower limb amputation in the
community. Diabetes Care 1998; 21:738-743.
Morrison EY. Diabetes foot amputations are the most frequent diabetes
complication in developing countries. IDF Bull. 1997; 42: 14-17.
Moss SE, Klein R, Klein B. The prevalence and incidence of lower extremity
amputation in a diabetic population. Arch. Intern. Med. 1992; 152: 610-616.
Moss SE, Klein R, Klein BE. Long-term incidence of lower- extremity amputations in
a diabetic population. Arch Fam Med. 1996; 5:391–398.
Moss SE, Klein R, Klein BE. The 14-year incidence of lower extremity amputations
in a diabetic population. The Wisconsin Epidemiolog Study of Diabetic Retinopathy.
Diabetes Care 1999; 22(6)951-959.
Mostaza JM, Manzano L, Suarez C, et al. Prevalence of asymptomatic peripheral
artery disease detected by the ankle-brachial index in patients with cardiovascular
disease. MERITO II Study. Med Clin (Barc) 2008; 131(15): 561.
Mueller Mi, Diamond JE, Elitto A, et al. Insensitivity, limited joint mobility and
plantar ulcers in patients with diabetes mellitus. Physical Therapy. 1989; 69: 453-
459.
Muller IS, De Grauw WJ, Van Gerwen WH, et al. Foot ulceration and lower limb
amputation in type 2 diabetic patients in Dutuch primary health care. Diabetes Care
2002; 25(3):570-574.
Muller LM, Gorter KJ, et al. Increased risk of common infections in patients with
type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41(3): 281-288.
Murabito JM, D’Agostino RB, Silbershatz H, et al. Intermittent claudication: risk
profile from the Framingham Heart Study. Circulation 1997; 96:44–9.
Murray HJ, Young MJ, Hollis S, et al. The association between callus formation, high
pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996; 13
(11):979-982.
National Committee for Clinical and Laboratory Standards. Method for broth
dilution antifungal susceptibility testing of filamentous fungi; approved standard
Second edition. M38A. 28(16). 2002.
National Committee for Clinical Laboratory Standards: Performance Standards
for Antimicrobial Susceptibility Testing: Twelfth Informational Standard. M100-
S12, vol.22, no. 1. Villanova, PA, National Committee for Clinical Laboratory
Standards, 2002.
Bibligraphy
209
National Diabetes Data Group. Diabetes in America, 2nd ed. Washington, DC, US
Government printing Office, 1995.
National Institute for Clinical Excellence. Type 2 Diabetes. Prevention and
Management of Foot Problems. Clinical Guideline 10. National Institute for Clinical
Excellence, London, UK. 2004.
Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of RAGE: a cell surface
receptor for advanced glycosylaton end products of proteins. J Biol Chem. 1992;
267: 14998-15004.
Nelson RG, Gohdes DM, Everhart JE, et al. Lower extremity amputations in NIDDM:
12-yr follow up study in Pima Indians. Diabetes Care. 1988; 11: 8-16.
Nelzén O, Bergqvist D, Lindhagen A. et al. Chronic leg ulcers: an underestimated
problem in primary health care among elderly patients. Journal of Epidemiology
and Community Health 1991; 45: 184–7.
Neuwirth C, Madec S, Siebor E, et al. TEM-89 beta- lactamase produced by a
Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations
in both TEM-59 (IRT-17) and TEM-3. Antimicrob. Agents Chemother. 2001; 45:
3591–3594.
Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot
ulcers: diagnosing and monitoring by leukocyte scanning with indium In111
oxyquinolone. JAMA. 1991; 266:1246-51.
Newman LG. Imaging techniques in the diabetic foot. Clin Podiatr Med Surg. 1995;
12:75–85.
Newton AC: Protein Kinase C: Structure, function, and regulation. J Biol Chem.
1995; 270: 28495-28498.
Nielsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputation
among Saudi Arabian patients with type 2 diabetes. Diabetes Res Clin Pract 1998;
41(1):63-69.
Norden C: Bone and joint infection. Curr Opin Infect Dis.1996; 9:109 –114.
O’Meara SM, Cullum NA, Majid M, et al. Systematic review of antimicrobial agents
used for chronic wounds. Br J Surg. 2001; 88: 4–21.
Oakley W, Caterall CF: Aetiology and management of lesions of the feet in diabetes.
Br Med J. 1956; 27:953 -955.
Oberdorfer K, Swoboda S, et al. Tissue and serum levofloxacin concentration in
diabetic foot infection patients. J Antimicrob Chemother 2004; 54(4): 836-839.
Bibligraphy
210
Obrosova I, Faller A, Burgan J, et al. Glycolytic pathway, redox state of NAD (P)-
couples and energy metabolism in lens in galactose fed rats. Effect on an aldose
reductase inhibitor. Curr Eye Res 1997; 16:34-43.
Olivencia JA. Pathophysiology of venous ulcers: surgical implications, review and
update. Dermatologic Surgery 1999; 25: 880–5.
O'Meara SM, Cullum NA, Majid M. et al. Systematic reviews of wound care
management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot
ulceration. Health Technology Assessment 2004; 4:1–237.
Oyibo SO, Jude EB, Tarawneh I, et al. The effect of ulcer size and site, patient’s age,
sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet
Med 2001; 18(2):133-138.
Pai MP, Rodvold KA, Schreckenberger PC, et al. Risk factors associated with the
development of infection with linezolid- and vancomycin resistant Enterococcus
faecium. Clin Infect Dis. 2002; 35:1269-1272.
Palumbo PJ, Melton LJI. Peripheral vascular disease and diabetes. In National
Diabetes Data Group(ed): Diabetes In America, 2nd ed (NIH publ. no. 495-1468).
Washington, DC, U.S. Government Printing Office. 1995:401-408.
Papademetriou V, Narayan P, Rubins H, et al. Influence of risk factors on
peripheral and cerebrovascular disease in men with coronary artery disease, low
high density lipoprotein cholesterol levels and desirable low density lipoprotein
cholesterol levels: Department of Veterans Affairs HDL Intervention Trial. Am Heart
J 1998; 136:734–740.
Park JE, Barbul A. understanding the role of immune regulation in wound healing.
Am J Surg 2004; 187: 11S-16S.
Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients
with diabetes and neuropathic foot lesions. N. Engl. J. Med. 1988; 318:1306.
Paterson DL and Bonomo RA. Extended-Spectrum β-Lactamases: a Clinical
Update. Clin Micbio Revs. 2005; 18(4): 657-686.
Paterson DL, Hujer KM, Hujer AM, et al. Extended-spectrum beta-lactamases in
Klebsiella pneumoniae bloodstream isolates from seven countries: Dominance and
widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob.
Agents Chemother 2003; 47:3554–3560.
Pathare NA, Bal A, Talvalkar GV, et al. Diabetic foot infections: a study of
microorganisms associated with the different Wagner grades. Ind J Pathol Microbiol
1998; 41:437–41.
Bibligraphy
211
Pecoraro RE, Ahroni J, Boyko EJ, et al. Chronology and determinants of tissue
repair in diabetic lower extremity ulcers. Diabetes 1991; 40: 1305-1313.
Pecoraro RE, Reiber G, Burgess EM. Pathways to diabetic limb amputation: basis
for prevention. Diabetes Care 1990; 13: 513.
Pendsey S: Epidemiological aspects of diabetic foot. J Diabetes Develop Countries
1994; 2: 37-38.
Percival L, Bowler P. Biofilms and their potential role in wound healing. Wounds
2004; 16:234–240.
Perna M, Romagnuolo J, Morgan K, et al. Preoperative hemoglobin A1c and post
operative glucose control in outcomes after gastric bypass for obesity. Surg Obes
Ret Disce 2011 (In press)
Peters EJ, Lavery LA, et al. Diabetic lower extremity infection: Influence of physical,
psychological, and social factors. J Diabetes Complications 2005; 19 (2): 107-112.
Pfeifer MA, Ross D, Schrange J, et al. A highly successful and novel model for the
treatment of chronic painful peripheral neuropathy. Diabetes Care 1993; 16:1103-
1115.
Philippon A, Labia R, Jacoby G. Extended-spectrum beta- lactamases. Antimicrob.
Agents Chemother 1989; 33:1131–1136.
Piarulli F, Sambataro M, Mincuci N, et al. Mild peripheral neuropathy prevents both
leg muscular ischaemia and activation of exercise induced coagulation in Type 2
diabetic patients with peripheral artery disease. Diabet Med 2007;10: 1099–104.
Pieper GM, Riaz-ul-Haq J. Activation of nuclear factor kappa B in cultured
endothelial cells by increased glucose concentration: prevention by calphostin C.
Cardiovasc Pharmacol 1997; 30:528-532
Pirart J. Diabetes mellitus and its degenerative complications: a prospective study
of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978 ; 1:168.
Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-
beta-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol
2004; 42:5715–5721.
Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabesity
Res 2003; 4: 271-281.
Poirel LE, Lebessi M, Castro C, et al. Nosocomial outbreak of extended-spectrum
beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens,
Greece. Antimicrob. Agents Chemother 2004; 48: 2277–2279.
Bibligraphy
212
Poirel LH, Mammeri, Nordmann P. TEM-121, a novel complex mutant of TEM-type
beta-lactamase from Enterobacter aerogenes. Antimicrob. Agents Chemother 2004;
48: 4528–4531.
Poirel LM, Gniadkowski, Nordmann P. Biochemical analysis of the ceftazidime-
hydrolysing extended-spectrum beta-lactamase CTX- M-15 and of its structurally
related beta-lactamase CTX-M-3. J. Antimi- crob. Chemother 2002; 50:1031–1034.
Polydefkis M, Griffin JW, Mcarthur J. New insights into diabetic polyneuropathy.
JAMA 2003; 290(10):1371-1376.
Pomposelli FB. Noninvasive evaluation of the peripheral arterial system in the
diabetic lower extremity. In: Management of foot problems , 2nd ed., pp. 138-148,
edited by GP Kozak, DR Campbell, RG Frykberg, and GM Hershaw, WB Saunders,
Philadelphia, 1995.
Pound N, Chipchase S, Treece K et al. Ulcer-free survival following management of
foot ulcers in diabetes. Diabet Med 2005; 22:1306-1309.
Powers AC. Diabetes mellitus. In Harrison’s principles of Internal Medicine (eds)
Fauci, Braunwald, Kasper et al. 17th edition.
Pratt TC. Gangrene and infection in the diabetic. Med Clin North Am 1965; 49:987-
1004.
Precoraro RE, Ahroni JH, Bokyo EJ, et al. Chronology and determinants of tissue
repair In diabetic lower-extremity ulcers. Diabetes Care 1991; 40:1305-1313, 1991.
Premalatha G, Ravikumar R, Sanjay R, et al. Comparison of colour duplex
ultrasound and ankle-brachial pressure index measurements in peripheral vascular
disease in type 2 diabetic patients with foot infections. J Assoc Physicians India
2002; 50: 1240-1244.
Premlatha G, Shanthirani S, Deepa R, et al. Prevalence and risk factors of
peripheral vascular disease in a selected South Indian populations. Diabetes Care
2000; 23(9): 1295-1300.
Pugliese G, Pricci F, Pugliese F, et al. Mechanisms of glucose enhanced extracellular
matrix accumulation in rat glomerular mesangial cells. Diabetes 1994; 43:478-490
Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic
view. Diabetes Metab Rev 1987; 3:463–524.
Radice MP, Power J Di Conza, Gutkind G. Early dissemination of CTX-M-derived
enzymes in South America. Antimicrob. Agents Chemother 2002; 46: 602–604.
Bibligraphy
213
Ragnarsson-Tennvll G, Apelqvist J. Health-economic consequences of the diabetic
foot lesions. Clin Infect Dis 2004; 39(2): S132-S139.
Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia:
a retrospective study of 194 cases. J Microbiol Immuno Infect 2007; 40(1):39-44
Ramachandran A, Jali MV, Mohan V, et al. High prevalence of diabetes in an
urban population in south India. BMJ 1988; 297: 587-90.
Ramachandran A, Snehalata C, Latha E, et al. Clustering of cardiovascular risk
factors in urban Asian Indians. Diabetes Care 1998; 21: 967-971.
Ramachandran A, Snehalatha C, Kapur A, et al. Diabetes Epidemiology Study
Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance
in India: National Urban Diabetes Survey. Diabetologia 2001; 44 :1094-101.
Ramachandran A, Snehalatha C, Latha E, et al. Impacts of urbanization on the
lifestyle and on the prevalence of diabetes in native Asian Indian population.
Diabetes Res Clin Pract 1999; 44: 207–213.
Raman Kutty V, Joseph A, Soman CR. High prevalence of type 2 diabetes in an
urban settlement in Kerala, India. Ethn Health 1999; 4: 231-239.
Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes and costs of foot ulcers
in patients with diabetes. Diabet Care 1999; 22(3):382-387.
Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers
in patients with diabetes. Diabetics Care 1999; 22:382-387.
Rao PV, Ushabala P, Seshaiah V, et al. The Eluru survey: prevalence of known
diabetes in a rural Indian population. Diabetes Res Clin Pract 1989; 7 :29-31.
Rasmussen B A, Bush K. Carbapenem-hydrolyzing beta-lac- tamases. Antimicrob.
Agents Chemother 1997; 41: 223–232.
Rathmann W, Ziegler D, Jahnke M et al. Mortality in diabetic patients with
cardiovascular autonomic neuropathy. Diabet Med 1993; 10:820-824.
Rauwerda JA. Foot debridement: anatomic knowledge is mandatory. Diabetes
Metab Res Rev 2000; 16 (1): S23-S26.
Rauwerda JA. Surgical treatrment of the infected diabetic foot. Diabetes Metab Rs
Rev2004, 20(1): S41-S44.
Raymakers JT, Houben AJ, et al. The effect of diabetes and severe ischaemia on the
penetration of ceftazidime into tissues of the limb. Diabetic Medicine 2001; 18(3):
229-234.
Bibligraphy
214
Reagan D, Doebbeling BN, Pfaller MA, et al. Elimination of coincident
Staphylococcus. aureus nasal and hand carriage with intranasal application of
mupirocin calcium ointment. Ann Intern Med 1991; 114:101-106.
Reiber GE, Bokyo EJ, Smith DG. Lower extremity foot ulcers and amputations in
diabetes. In National Diabetes Data Group (ed): Diabetes in America, 2nd ed (NIH
publ. no.95 1468). Washington, DC, U.S. Government Printing Office: 409-428, 1995.
Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am. J. Surg.
1998; 176(Suppl. 2A):5S–10S.
Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with
diabetes mellitus: a case control study. Ann Intern Med 1992; 117: 97–105.
Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower
extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;
22:157-162.
Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: The
Diabetic foot. 2001; edited by JH Bowker and MA Pfeifer, Mosby, St. Louis pp 13-32.
Reiber GE. Ledoux WR. Epidemiology of diabetic foot ulcers and amputations:
evidence for prevention. In Williams R, Herman W, Kinmonth KI, Wareham NJ, eds.
The evidence base for diabetes care, chichester: J. Wiley & Sons 2002: 642 – 665.
Reiber GE: Who is at risk of limb loss and what to do about it. J Rehabil Res Dev.
1994; 31:357–362.
Reike H, Schwerpunkt Fubklink. Qualitats standards verhindern Amputationen,
SchulungsProft Diabetes 1997; 3 : 14–20.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes
mellitus. Diabetes Care 1997; 20:1183.2.
Resnick HE, Carter EA, Sosenko JM, et al. Incidence of lower extremity amputation
in American Indians:The Strong Heart Study. Diabetes Care 2004; 27(8):1885-1891.
Resnick HE, Valsania P, Phillips CL. Diabetes mellitus and non-traumatic lower
extremity amputation in black and white Americans: The national health and
nutrition examination survey epidemiological follow-up study, 1971-1992. Arch
Intern Med 1999; 159:2470-2475.
Retsema JA, English AR, Girard A. Sulbactam: ampicillin: in vitro spectrum,
potency, and activity in models of acute infection. Rev Infect Dis 1986; 8: S528–34.
Bibligraphy
215
Rheeder P, Van Wyk JT, Stolk RP, Grobbee DE. Assessing peripheral arteries in
South African black women with type 2 diabetic patients. S Afr Med J
2004;94(5):379-83.
Richards P, Sisson PR, Hickman JE. Microbiology and mortality of brain abscess in
Newcastle-upon-Tyne between 1979 and 1988. Scand J Infect Dis 1990; 22: 511–8.
Richmond W. Scand J Clin Lab Invest 1972; 29(Suppl 26), Abstract 3: 25.
Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive
protein and risk of developing peripheral vascular disease. Circulation 1998; 97:
425–42 8.
Rieber GE, Lipsky BA, Gibbons GW. The burden of the diabetic foot ulcer. Am J Surg
1998; 176(2a): 5-10.
Rissau W. Mechanism of angiogenesis. Nature 1997, 386: 671-674.
Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patient at high risk
for lower extremity amputation in a primary health care setting: A prospective
evaluation of simple screening criteria. Diabetes Care 1992; 15(10):1386-1389.
Robinson LR, Stolov WC, Rubner DE, et al. Height is an independent risk factor for
neuropathy in diabetic men. Diabetes Res Clin Pract 1992; 16:97-102.
Robson MC, Mannari RJ, Smith PD, et al. Maintenance of wound bacterial balance.
Am J Surg 1999; 178:399–402.
Robson MC. Wound infection: a failure of wound healing caused by an imbalance of
bacteria. Surgical Clinics of North America 1997; 77, 637–650.
Rose CM, Reilly KJ, Haith LR. Emergence of resistance of vancomycin-resistant
Enterococcus faecium in a thermal injury patient treated with quinupristin-
dalfopristin and cultured epithelial autografts for wound closure. Burns 2002;
28:696-698.
Rosenblum BI, Pomposelli FB, Giurini JM, et al. Maximizing foot salvage by a
combined a p p roach to foot ischemia and neuropathic ulceration in patients with
diabetes: a 5-year experience. Diabetes Care 1994; 17:983–987.
Rubello D, Casara D, Maran A, et al. Role of anti-granulocyte Fab’ fragment
antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition
protocol, interpretation criteria and clinical results. Nucl Med Commun 2004; 25:
39–47.
Sadikot SM, Nigam A, Das S, et al. The burden of diabetes and impaired fasting
glucose in India using the WHO 1999 critetia. Prevalence of diabetes in India study
Bibligraphy
216
(PODIS). On behalf of Diabetes India, Diabetes Research and Clinical Practice 2004;
66: 301-307.
Salgado CD, Farr BM, Calfee DP. Community acquired Methicillin eresistant
StaphylococcuS. aureus: A meta-analysis of prevalence and risk factors. Clin Infect
Dis 2003; 36:131-139.
Sapico FL, Canawati HN, Witte JL, et al. Quantitative aerobic and anaerobic
bacteriology of infected diabetic feet. J Clin Microbiol. 1980; 12:413–20.
Sapico FL, Witte JL, Canawati HN, et al. The infected foot of the diabetic patient:
quantitative microbiology Guidelines for Diabetic Foot Infections • CID 2004:39 (1
October) 905 and analysis of clinical features. Rev Infect Dis. 1984; 6(Suppl 1):
S171 6.
Sapico FL. Foot Infections in the Diabetic: A Review of Microbiologic Aspects. Phil J
Microbiol Infect Dis 1985; 14(2): 52-54.
Sapico RL. Foot infections in patients with diabetes mellitus. J Am Pediatr Med
Assoc 1989;79: 482–485.
Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose
stimulation of transforming growth factor-alpha gene transcription. J Biol Chem
1996; 271:15237-15243.
Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol.
1998; 32 (Suppl 3): S2-S13.
Schilling JA. Wound healing. Surg Clin North Am 1976; 56: 859-874.
Schmidt AM, Hori O, Cao R, et al: RAGE: A novel cellular receptor for advanced
glycation end products. Diabetes 1996; 45(Suppl 3) : S77-S80.
Schmidt AM, Stern DM. RAGE: A new target for the prevention and treatment of the
vascular and inflammatory complications of diabetes. Trends Endocrinol Metab
2000; 11: 368-375.
Schmidt K, Debus ES, Jeßberger S, et al. Bacterial population of chronic crural
ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer?
Vasa 2000; 29: 62–70.
Schoenhaus HD, Wernick E, Cohen R. Biomechanics of the diabetic foot. In: the
High Risk Foot in Diabetes Mellitus, p. 125, edited by RG Frykberg, Churchill
Livingstone, New York, 1991.
Schraibman IG. The significance of beta-haemolytic streptococci in chronic leg
ulcers. Annals of the Royal College of Surgeons of England 1990; 72: 123–124.
Bibligraphy
217
Schubert S, Heesemann J. Infections in diabetes mellitus [in German]. Immun
Infekt. 1995; 23:200–204.
Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic
approach to wound management. Wound Repair Regen 2003; 11(Suppl 1):S1–28.
Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of
bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Antimicrob Agents Chemother 2006; 50:1257-1262.
Schwiersch U, Lang N, Wildfeuer DA. Concentration of sulbactam and ampicillin in
serum and the myometrium. Drugs 1986; 31:26–8.
Scottish Intercollegiate Guidelines Network (SIGN) No. 26 The Care of Patients
with Chronic Leg Ulcer. A National Clinical Guideline. No. 26. SIGN Publication,
Edinburgh, UK 1998.
Seabrook GR, Edmiston CE, Schmitt DD. Comparison of serum and tissue antibiotic
levels in diabetes-related foot infections. Surgery 1991;110:671–7.
Sehgal SC, Arunkumar BK. Microbial flora and its significance in pathology of sickle
cell disease leg ulcers. Infection 1992 ; 20:86-88.
Selby JV, Karter AJ, Ackerson LM, et al. Developing a prediction rule from
automated clinical database to identify high-risk patients in a large population with
diabetes. Diabetes Care 2001; 24(9):1547-1555.
Selby ZV, Zhang D. Risk factors for lower extremity amputation in persons with
diabetes. Diabetes Care 1995; 18(4): 509-516.
Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated
hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;
141: 421–31.
Serra J. Overview of neuropathic pain syndromes. Acta Neurol Scand 1999; 173
(Suppl):7-11.
Shah SK, Saikia M, Burman NN, et al. High prevalence of type 2 diabetes in
urban population in north eastern India. Int J Diabetes Dev Countries 1999; 19 :
144-7.
Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with
diabetes. Diabetes Care 2003; 26 (2): 510-513.
Shah JE, Sicree RA, Zimmet P. Global estimation of the prevalence of diabetes for
2010 and 2030. Diab Res Clin Prac 2010; 87(4); 4-14.
Bibligraphy
218
Shah M, Mohanraj M. High levels of fusidic acid-resistant Staphylococcus aureus in
dermatology patients. British Journal of Dermatology 2003; 148: 1018–20.
Shahid M, Malik A, Adil M, et al. Comparison of beta-lactamase genes in clinical and
food bacterial isolates in India. J Infect Dev Ctries 2009; 3(8):593-598
Shankar EM, Mohan V, Premalatha G, et al. Bacterial etiology of diabetic foot
infections in South India. Eur J Intern Med 2005;16:567–570.
Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes
mellitus. Arch Neurol 2002; 59:758-765.
Sharp CS, Bessman AN, Wagner FW, et al. Microbiology of deep tissue in diabetic
gangrene. Diabetes Care 1965; 1: 289-292.
Sharp CS, Bessman AN, Wagner FW, et al. Microbiology of superficial and deep
tissues in infected diabetic gangrene. Surg Gynecol Obstet 1979; 1149:217-249.
Shaw JE, Boulton AJM. The pathogenesis of diabetic foot problems. An overview.
Diabetes1997 ; 46(suppl.):S58-S61.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. DRCP 2010. 87(1): 4-14.
Shea JD. Pressure sores: classification and management. Clin Orthop 1975; 112 :
89 – 100.
Sheehan P, Jones P, Caselli A, et al. Percent change in wound area of diabetic foot
ulcers over a 4-week period is a robust predictor of complete healing in a 12-week
prospective trial. Diabetes Care 2003; 26(6):1879-1882.
Shobha KL , Ramachandra L, Rao G, et al. Extended Spectrum beta-Lactamases
(ESBL) in gram negative bacilli at a tertiary care hospital. Journal of Clinical and
Diagnostic Research 2009; 3:1307-1312.
Siami G, Christou N, Eiseman I. et al. Clinafloxacin versus piperacillin-tazobactam in
treatment of patients with severe skin and soft tissue infections. Antimicrobial
Agents and Chemotherapy. 2001 ; 45: 525–31.
Siitonen OL, Niskanen LK, Laakso M, et al. Lower extremity amputation in diabetic
and nondiabetic patients. Diabetes Care 1993; 16:16-20.
Simmons Z, Feldman E. Update on diabetic neuropathy. Curr Opin Neurol 2002; 15:
595–603.
Sims D, Keating SE, DeVincentis AF. Bacteriology of diabetic foot ulcers. J Foot Surg
1984; 23:149–51.
Bibligraphy
219
Singal A, Thami GP. Topical antibacterial agents in dermatology. Journal of
Dermatology 2003; 30: 644–648.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes.
JAMA. 2005; 293:217–228.
Sinnock P. Reduced hospital utilization and cost savings associated with diabetes
patient education. J Insurance Med 1986 ;18:24–30.
Sirot DJ. Sirot R. Labia A. et al. Transferable resistance to third- generation
cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-
1, a novel beta-lactamase. J. Antimicrob. Chemother 1987; 20:323–334.
Smith L, Plehwe W. Mc Gill M, et al. Foot bearing pressure in patients with
unilateral diabetic foot ulcers. Diabet Med 1989; 6:573-575.
Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in
StaphylococcuS. aureus. N Engl J Med 1999; 340:493-501.
Sosenko JM, Gladia MT, Fournier AM et al. Body stature as a risk factor for diabetic
sensory neuropathy. Am J Med 1986; 80:1031-1034.
Sougakoff W S. Goussard GG, Courvalin P. Plasmid- mediated resistance to third-
generation cephalosporins caused by point mutations in TEM-type penicillinase
genes. Rev. Infect. Dis 1988; 10:879–884.
Spann CT, Tutrone WD, Weinberg JM. et al. Topical antibacterial agents for wound
care: a primer. Dermatologic Surgery 2003; 29: 620–626.
Sridhar GR, Rao PV, Ahuja MMS. Epidemiology of diabetes and its complications.
In: RSSDI textbook of diabetes mellitus. Hyderabad: Research Society for the
Study of Diabetes in India 2002: 95-112.
Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997;
77: 575-586.
Stess RM, Jensen SR, Mirmiran R. The role of dynamic planter pressures in diabetic
foot ulcers. Diabetes Care 1997; 20(5):855-858.
Steven PM, William RH: Peripheral Arterial Disease in Patients With Diabetes:
Journal of the American College of Cardiology 2006 ; 47: 5.
Stevens MJ, Goss DE, Foster AVM, et al. Abnormal digital pressure measurements in
diabetic neuropathic foot ulceration. Diabetic Med 1993; 10:909-915.
Stokes IAF, Faris IB, Hutton WC. The neuropathic ulcer and loads on the foot in
diabetic patients. Acta Orthop Scand 1975; 46(5):839-847.
Bibligraphy
220
Stovring H, Andersen M, Beck-Nielsen H, et al. Rising prevalence of diabetes:
evidence from a Danish pharmaco-epidemiological database. Lancet 2003;
362:537–538.
Streit JM, Jones RN, Sader HS, et al. Assessment of pathogen occurrences and
resistance profiles among infected patients in the intensive care unit: report from
the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J
Antimicrob Agents 2004; 24: 111-118.
Studer RK, Craven PA, De Rubertis FR. Role for protein kinase C in the mediation
of increased fibronectin accumulation by mesangial cells grown in high glucose
medium. Diabetes 1993; 42:118-126.
Sturenburg E, Kuhn A, Mack D, et al. A novel extended- spectrum beta-lactamase
CTX-M-23 with a P167T substitution in the ac- tive-site omega loop associated
with ceftazidime resistance. J. Antimicrob. Chemother 2004; 54:406–409.
Sykes RB, Bush R. Physiology, biochemistry and inactivation of beta-lactamases.
1982. 155–207. In R. B. Morin and M. Gorman (ed.), The chemistry and biology of
beta-lactam antibiotics, vol. 3. Academic Press, London, England.
Takeda S, Yasunaka K, Kono K, et al. Methicillin resistant Staphylococcus aureus
(MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the
Fukuoka city area. Int J Antimicrob Agents 2000; 14(1):39-43.
Tamas K, Ildiko K, Edit G, et al. Capillary electrophoresis study of outer membrane
proteins of Pseudomonas aeruginosa strains upon antibiotic treatment, J
Chromatogr A 2002; 979: 277–284.
Tammelin A, Lindholm C, Hambraeus A. Chronic ulcers and antibiotic treatment.
Journal of Wound Care 1998; 7: 435–7
Tan JS, Friedman NM, Hazelton-Miller C, et al. Can aggressive treatment of diabetic
foot infection reduce the need for above-ankle amputation? Clin Infect Dis 1996; 23:
286-291.
Tanaka S, Avigad G, Brodsky B, et al. Glycation induces expansion of the molecular
packing of collagen. J Mol Bio 1988 ; 203:495-505.
Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N
Engl J Med 2000;342:1835–1837.
Taylor LM Jr, Moneta GL, Sexton GJ, et al. Prospective blinded study of the
relationship between plasma homocysteine and progression of symptomatic
peripheral arterial disease. J Vasc Surg 1999; 29:8–19.
Bibligraphy
221
Tentolouris N, Al-Sabbagh S, Walker MG, et al. Mortality in diabetic and
nondiabetic patients after amputations performed from 1990 to 1995: a year
follosw up study. Diabetes Care. 2004 ; 27: 1598-1604.
Tentolouris N, Jude EB, Smirnof I, et al. Methicillin- resistant Staphylococcus.
aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999; 16:767–
771.
Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant
Staphylococcus. aureus in infected and uninfected diabetic foot ulcers. Clin
Microbiol Infect 2006;12:186–189.
The Diabetes Control and Complications Trial Research Group. The effect of
intensive treatment of diabetes on the development of long term complications in
insulin dependent diabetes mellitus. N. Engl. J. Med. 1993; 329:977-986.
The Global Lower Extremity Amputation Study Group: Epidemiology of lower
extremity amputation in centres in Europe, North America and East Asia. Br J Surg
2000; 87(3):328-337..
The International Working Group on the Diabetic Foot. The International
Consensus on the Diabetic Foot. The International Working Group on the Diabetic
Foot, Amsterdam, Netherlands 1999.
Thomas PK. Metabolic neuropathy. J R Coll Physicians Lond 1973; 7:154-160.
Thompson DE. The effects of mechanical stress on soft tissue. 1988; In: The
diabetic foot, Levin ME, O'Neil LW (eds) ed 4., CV Mosby, St. Louis: 83.
Thornalley PJ. The glyoxalase system: new developments towards functional
characterization of a metabolic pathway fundamental to biological life. Biochem J
1990; 269:1.
Tice A, Hoaglund P, Giani G, et al. Outcomrs of osteomyelitis among patients treated
with outpatient parenteral antimicrobial therapy. Am J Med 2003; 114(9): 723-728.
Tomlinson DR. Mitogen activated protein kinases as glucose tranducers for
diabetic complications. Diabetologia 1999; 42:1271-1281.
Trautner C, Hasstert B, Giani G, et al. Incidence of lower limb amputations and
diabetes. Diabetes Care 1996; 19(9): 1006-1009.
Trengove NJ, Stacey MC, McGechie DF, et al. Qualitative bacteriology and leg ulcer
healing. J Wound Care 1996; 5: 277–280.
Trinder P. Determination of glucose in blood using glucose oxidase with an
alternative oxygen accepter. Ann Clin Biochem 1969;6:24-27.
Bibligraphy
222
Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of
StaphylococcuS. aureus. Lancet 2001; 358:207-208.
Tsuchiya M, Suzuki E, Egawa K, et al. Abnormal peripheral circulation in type 2
diabetic patients with normal anklebrachial index associates with coronary
atherosclerosis, large artery stiffness, and peripheral vascular resistance. Diabet
Res Clin Pract 2005;70(3):253–62.
Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea,
metformin, or insulin in patients with type 2 diabetes mellitus: progressive
requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study
(UKPDS) Group. JAMA 1999;281:2005–2012.
Twum-Danso K, Grant C, Al-Suleiman SA, et al. Microbiology of postoperative
wound infection: a prospective study of 1770 wounds. J. Hosp. Infect 1992; 21:29-
37.
United Kingdom Prospective Diabetes Study Group (UKPDS). Intensive blood
glucose control with sulfonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes (UKPDS).
Lancet 1998; 352:837-853.
Urbani-Rovan V, Gubina M. Infection in superficial diabetic foot ulcers. Clinical Infectious Diseases. 1997; 25, S184–5.
Uusitupa MI, Niskanen LK, Siitonen O, et al. 5-year incidence of atherosclerotic
vascular disease in relation to general risk factors, insulin level, and abnormalities
in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic
subjects. Circulation 1990; 82:27–36.
Valentina G, Lalitha MK. Isolation and identification of bacteria from pus (including
drainage tube, catheter, ear, eye and genital swabs). In Myer's and Koshi's Manual
of Diagnostic Procedures in Medical Microbiology and Immunology/Serology
Vellore, India: Christian Medical College and Hospital. All India Press: Poindicherry,
India, 2001; 38–49.
Van Damme H, Rorive M, Lavery LA, et al. Amputations in diabetic patients: A plea
for footsparing surgery. Acta chir Belg 2001; 101(3): 123-129.
Van Houtum W, Lavery LA. Outcomes associated with diabetes-related
amputations in the Netherlands and in the state of California. J Int Med 1996;
240:227-231.
Vesco L, Boulahdour H, Hamissa S, et al. The value of combined radionuclide and
magnetic resonance imaging in the diagnosis and conservative management of
Bibligraphy
223
minimal or localized osteomyelitis of the foot in diabetic patients. Metabolism
1999; 48: 922–927.
Veves A, Murray H, Young MJ, et al. Do high foot pressures lead to foot ulcerations?:
A prospective study [abstract]. Diabetologia 1991; 34(2):A40.
Veves A, Murray H, Young MJ, et al. The risk of foot ulceration in diabetic patients
with high foot pressures: a prospective study. Diabetologia 1992; 35:660.
Vijay V, Snehalatha C, Terin M, et al. Sociocultural practices that may affect the
development of the diabetic foot. IDF Bull 1997:42;10-12.
Viswanathan V, Jasmine JJ, Snehalatha C, et al. Prevalence of pathogens in diabetic
foot infection in south Indian type 2 diabetic patients. JAPI 2002; 50:1013-1016.
Viswanathan V, Kumpatla S. Indian Diabetic Amputation Study Group. Patterns
and causes of amputation in diabetic patients: A multicentre study from India. JAPI
2011; 59: 148-151
Viswanathan V, Thomas N, Tandon N, et al. Profile of diabetic foot complications
and its associated complications: a multicentric study from India. JAPI. 2005; 53:
933-936.
Viswanathan V. The diabetic foot: Perspectives from Chennai, south India. Int J
Lower Extrem Wounds 2007;6: 34-36.
Von Eiff C, Peters G, and Heilmann C. Pathogenesis of infections due to coagulase-
negative staphylococci. Lancet Infect. Dis. 2002; 2:677-685.
Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant
Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis. 1994; 13:50-55.
Wagner A, Reike H, Angelkort B. Highly resistant pathogens in patients with
diabetic foot syndrome with special reference to methicillin- resistant
Staphylococcus aureus infections [in German]. Dtsch Med Wochenschr 2001;
126:1353–1356.
Wagner FW: The dysvascular foot: a system of diagnosis and treatment. Foot Ankle
1981; 2:64 -122.
Waldvogel FA, Vasey H. Osteomyelitis: the past decade. N Engl J Med
1980;303:360—70.
Wall IB, Davies CE, Hill KE, et al. Potential role of anaerobic cocci in impaired
human wound healing. Wound Repair Regen 2002;10:346-353.
Bibligraphy
224
Walters DP, Gatling W, Mullee MA, et al. The distribution and severity of diabetic
foot disease: A community study with comparison to a non-diabetic group. Diabet
Med 20021992; 9:354-358.
Warnke JP, Wildfeuer A, Eibel G. Pharmacokinetics of ampicillin: sulbactam in
patients undergoing spinal microneurosurgical procedures. Int J Clin Pharm Ther
1998;36:253–257.
Wautier JL, Wautier MP, Schmidt AM, et al. Advanced glycation endproducts
(AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific
receptor inducing oxidant stress in the vasculature: a link between surface-
associated AGEs and diabetic complications. Proceedings National Academy of
Sciences USA 1994; 91: 7742–7746.
Weerasuriya N, Siribaddana S, Dissanayake A, et al. Long-term complications in
newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM 1998;
91:439–443.
Wells-Knecht KJ, Zyzak DV, Litchfield JE, et al. Mechaninsm of autoxidative
glycosylation: identification of glyoxal and arabinose as intermediates in the
autoxidative modification of proteins by glucose. Biochemistry 1995; 34:3702.
Wheat LJ, Allen SD, Henry , et al. Diabetic foot infections: Bacteriologic analysis.
Arch Intern Med 1986; 146: 1935-1940.
WHO Consultation Group. Definition, diagnosis and classification of diabetes
mellitus and its complications, 2nd ed. Part 1: Diagnosis and classification of
diabetes mellitus WHO/NCD/NCS/99. Geneva: World Health Organisation, 1999:1–
59.
WHO Study Group. Diabetes mellitus. Technical Report Series 727. Geneva: World
Health Organization, 1985
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year
2000 and projections for 2030, Diabetes Care 2004; 27 (5): 1047–1053.
Williams B, Gallacher B, Patel H, et al. Glucose induced protein kinase C activation
regulates vascular permeability factor mRNA expression and peptide production by
human vascular smooth muscle cells in vitro. Diabetes 1997;46:1497-1503.
Williams DT, Hilton JR, et al. Diagnosing foot infection in diabetes. Clin Infect Dis
2004, 39(2): S83-S86.
Williamson JR, Chang K, Frangos M, et al: Hyperglycemic pseudohypoxia and
diabetic complications. Diabetes. 1993; 42:801-813.
Bibligraphy
225
Wilson R. Upward trend in acute anaphylaxis continued in 1998–9. British Medical
Journal 2000; 321, 1021.
Wing R, Goldstein MG, Acton KJ, et al. Behavioral science research in diabetes:
Lifestyle changes related to obesity, eating behavior, an physical activity. Diabetes
Care 2001; 24:117-123.
Wise R, Donovan IA, Andrews JM. Penetration of sulbactam and ampicillin into
peritoneal fluid. Antimicrob Agents Chemother 1983;24:290–292.
Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am 1997;
77: 509-528.
Wollesen F, Dahlen G, Berglund L, et al. Peripheral atherosclerosis and serum
lipoprotein (a) in diabetes. Diabetes Care 1999; 22:93–98.
Xaa A. The prevention of progression of arterial disease and diabetes (POPADA)
trial. BMJ 2008;337: a1840.
Xia P, Inoguci T, Kern TS, et al. Characterization of the mechanisms for the chronic
activation of diacylglycerol-protein kinase C pathways in diabetes and
hypergalactosemia. Diabetes 1994; 43:1122-1129.
Ya Y, Sturdevant DE, Villaruz A, et al. Factors characterizing Staphylococcus
epidermidis invasiveness determined by comparative genomics. Infect. Immun.
2005 ; 73:1856-1860.
Yan JJ, Ko WC, Tsai SH, et al. Dissemination of CTX-M-3 and CMY-2 beta-
lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin.
Microbiol 2000; 38:4320–4325.
Yan SF, Ramasamy R, Naka Y, et al. Glycation and inflammation, and RAGE: A
scaffold for the macrovascular complications of diabetes and beyond. Circ Res
2003; 93: 1159-1169.
Yerneni KK, Bai W, Khan BV, et al. Hyperglycemia induced activation of nuclear
transcription factor kappa B in vascular smooth muscle cells. Diabetes 1999;
48:855-864
Yorek MA, Wiese TJ, Davidson EP, et al. Reduced motor nerve conduction velocity
and Na(+)-K(+)-ATPase activity in rats maintained on L-fructose diet. Reversal by
myo-inositol supplementation. Diabetes 1993; 42:1401-1406.
Young MJ. Adams JE, Anderson GF, et al. Medial arterial calcification in the feet of
diabetic patients and matched non diabetic control subjects. Diabetologia. 1993
;36:615-621.
Bibligraphy
226
Yun HJ, Lee SW, Yoon GM, et al. Prevalence and mechanisms of low- and high-level
mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob
Chemother. 2003; 51:619-623.
Zanone MM, Burchio S, Quadri R, et al. Autonomic function and autoantibodies to
autonomic nervous structures, glutamic acid decarboxylase and islet tyrosine
phosphatase in adolescent patient with IDDM. J Neuroimmunol 1998; 87:1-10.
Zargar AH, Khan AK, Masoodi SR, et al. Prevalence of type 2 diabetes mellitus and
impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent.
Diabetes Res Clin Pract 2000; 47: 135-6.
Zhang P, Engelgau M, Valdez R, et al. Costs of screening for prediabetes among U.S.
adults: A comparison of different screening strategies. Diabetes Care 2003;
26:2536-2542.
Zhang Z, Apse K, Stanton RC. High glucose decreases glucose-6-phosphate
dehydrogenase (G6PD) activity and impairs G6PD response to oxidative stress, thus
predisposing cells to cell death in cultured bovine aortic endothelial cells. Diabetes.
1999; 48(Suppl 1):A127
Zierold AA. Gangrene of the extremity in the diabetic. Ann Surg 1939; 110:723-
730.
Zimmet P. Type 2 (Non-insulin dependent) diabetes: an epidemiological overview.
Diabetolgia. 1982; 22: 399-411.
Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in
adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis
and prediction of insulin dependency. Diabet Med 1994;11: 299–303.
Zochodone DW: Diabetic polyneuropathy: an update. Curr Opin Neurol 2008;
21:527–533.